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Impact of Prenatal Heavy Metals Exposure on Birth Outcomes and Newborns 
Leucocytes Telomere Length in Myanmar 
（妊娠期における重金属暴露が出生アウトカム及び新生児の白血球テロメア長
に与える影響：ミャンマーにおける研究） 
ABSTRACT 
Introduction: Arsenic, cadmium and lead are well-known environmental contaminants 
and their toxicity at low concentrations is a target of scientific concern. Through trans-
placental exposure, these metals can accumulate in fetal tissues, extending the risk of 
fetal toxicity. Meanwhile, heavy metals exposure appears to modify telomere length 
(TL), which may predispose a person to adverse health risks. Information on newborn 
TL is important because TL later in life is mainly influenced by the TL at birth, 
meaning that having a short or long TL is greatly defined before adulthood. However, 
the determinants of TL at birth were poorly explained.  This study aimed to examine the 
extent of heavy metals contamination among a Myanmar population. This study also 
identified the potential effects of prenatal heavy metals exposure on birth outcomes 
among pregnant women and newborns in Myanmar. In addition, this study determined 
whether prenatal heavy metals exposure has an impact on newborn leucocyte TL. For a 
better understanding of the etiologic pathway, this study also determined whether heavy 
metals-induced TL shortening triggers the occurrence of adverse birth outcomes. 
 
 
viii 
 
Methods: A birth-cohort study was conducted among 419 pregnant women in Myanmar. 
At their first visit, face-to-face interviews were performed, and maternal spot urine was 
collected. Cord blood samples were collected at the time of delivery during follow-up. 
Urinary arsenic, cadmium, lead and selenium concentrations were measured by 
inductively coupled plasma mass spectrometry (ICP-MS) and adjusted for creatinine. 
TL was measured by quantitative real-time polymerase chain reaction (PCR), and 
relative TL was calculated as the ratio of telomere repeats product to a single-copy gene 
(T/S ratio). We examined the prenatal exposure of arsenic, cadmium and lead and their 
associations with adverse birth outcomes and newborn TL using multivariable logistic 
and linear regression analysis, respectively. Later, we determined whether a shorter TL 
was associated with risks of adverse birth outcomes using logistic regressing analysis. 
Results: The median values of adjusted urinary arsenic, cadmium, selenium and lead 
concentrations were 74.2, 0.9, 22.6 and 1.8 μg/g creatinine, respectively. Prenatal 
cadmium exposure was positively associated with risk of low birth weight (adjusted 
odds ratio (AOR) = 4.79, 95% confidence interval (CI): 1.25, 18.37, p = 0.022) after 
adjusting for maternal age, maternal education, the baby’s sex, smoking status, 
primigravida, antenatal visits and selenium concentration. However, maternal heavy 
metals concentration was not significantly associated with preterm delivery. There was 
an independent inverse association between prenatal arsenic (lowest vs highest quartile, 
coefficient = - 0.13, 95% CI: - 0.22, - 0.03, p = 0.002), cadmium (lowest vs highest 
quartile, coefficient = - 0.19, 95% CI: - 0.30, - 0.08, p < 0.001), and lead exposure 
(lowest vs highest quartile, coefficient = - 0.11, 95% CI: - 0.20, - 0.02, p = 0.020) and 
newborn TL, even after adjusting for maternal age, education, ethnicity, smoking status, 
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parity, gestational age, mode of delivery, the baby’s sex, birth weight and selenium 
concentration. Newborn TL was not significantly associated with any adverse birth 
outcomes. 
Conclusions: The present study determined that Myanmar mothers are highly exposed 
to cadmium. Prenatal maternal cadmium exposure was associated with an increased risk 
of low birth weight. This is also the first study to determine the impact of prenatal heavy 
metals exposure on newborn TL. The present study also identified that arsenic, 
cadmium and lead exposure could shorten TL, even in utero exposure. Since the TL at 
birth could predict the TL later in life, future public health measures should integrate 
interventions to reduce heavy metals contamination, with special emphasis on pregnant 
women. However, the risk of adverse birth outcomes was not associated with newborn 
leucocyte TL. 
Keywords: heavy metals, birth outcome, telomere length, newborn, Myanmar
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Chapter 1: Introduction 
 
1.1 Heavy Metals Exposure and Health 
Toxic heavy metals such as arsenic, cadmium and lead are naturally or 
anthropogenically dispersed in the environment [1, 2]. They may enter the human body 
through dermal contact, oral and/or inhalational routes [1]. Once entered, they are 
deposited into the human tissues with lengthy half-lives and subsequently, may pose 
several health hazards [1-3]. The state of toxicity in the body is influenced not only by 
exposure to high concentrations but also by the gradual accumulation of lower 
concentrations of heavy metals when the detoxification process takes place at a much 
slower rate than accumulation [1].  
Arsenic is a well-known toxic heavy metal and recognized as a human 
carcinogen [4, 5]. It naturally occurs in groundwater and its contamination has become a 
severe public health concern, especially when it is the primary source of drinking water 
for people living in contaminated areas [4, 6]. Worldwide, approximately 200 million 
people are suffering from chronic arsenic toxicity through arsenic-contaminated 
drinking water [4, 6, 7]. India and Bangladesh are particularly notable for their high 
arsenic contamination in groundwater with a large affected population size and 
relatively severe health effects [4]. Several countries across Southeast Asia were 
recently identified for groundwater arsenic contamination including Indonesia, Vietnam, 
Thailand, Cambodia, Laos, and Myanmar [4, 8]. Arsenic toxicity may result in both 
acute and chronic poisoning mostly through ingestion [9]. Several studies have proved 
that long-term arsenic exposure has adverse impacts on human health; causing skin 
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lesions, cardiovascular diseases, neurological complications, reproductive disorders, 
respiratory disorders, malignant diseases and non-malignant diseases [10-15]. 
Furthermore, arsenic passes the placental barrier from the mother to the fetus, further 
extending the health consequences [16]. 
Cadmium is a ubiquitous element in the environment and is toxic even at low 
concentrations [1, 17]. The ‘itai-itai’ disease in Japan brought the world’s attention to 
the dangers of environmental cadmium exposure and has led to numerous reports on the 
health risks of cadmium among human populations [18, 19]. The general population can 
be exposed to cadmium mostly through the diet, tobacco smoking and industrial 
activities [18]. Cadmium exposure primarily affects the kidney, liver and bones; 
however, growing evidence indicates that cadmium exposure, even at a low 
concentration, also has a carcinogenic effect and is associated with risks of chronic 
disease [18, 20-22]. Moreover, cadmium can extend the health risks to the fetus and 
greatly accumulate in the placenta [20, 23]. Meanwhile, it can inhibit the synthesis of 
hormones, such as progestogens, testosterone, leptin, and thyroid hormones, by acting 
as an endocrine disruptor which eventually has effects later in life [24, 25]. 
Lead is also an environmental contaminant that is naturally found at low 
concentrations in the earth’s crust; perhaps many industrial activities have predisposed 
its widespread occurrence [1, 26-28]. The general population is mostly exposed to lead 
through inhalation or ingestion, equally [1, 2]. The degree of lead exposure varies 
broadly across regions depending on urbanization, industrialization and lifestyle [27, 
28]. Environmental exposure to lead poses a major health challenge, particularly, its 
neurotoxic effects consistently threaten developing children [28-30]. Lead exposure can 
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also contribute to the etiological backgrounds of many diseases including renal, 
neurological, haematological, and cardiovascular diseases [28]. It is reported that 
inorganic lead exhibits mutagenic, clastogenic and carcinogenic properties [26]. Like 
arsenic and cadmium, lead can also easily pass through the placenta and accumulate in 
fetal tissues [3]. 
Selenium naturally exists in the environment and is unevenly distributed over 
the earth’s surface [31]. Humans consume selenium from foods, and the selenium 
content of foods varies depending on the selenium content of soil where the foods are 
produced [31-33]. Selenium is one of the essential nutrients for the detoxification of 
oxidative stress, owing to the active site of glutathione peroxidase [32, 34, 35]. The 
antioxidant effect of selenium plays a significant role in anti-carcinogenesis since it 
limits DNA damage induced by oxidative stress [31, 32]. In addition, high selenium in 
the form of selenoenzymes or selenoproteins can prevent the generation of oxidized 
low-density lipoprotein, thereby regulating the plasma cholesterol level [32]. It was 
previously reported that selenium deficiency can predispose humans to serious health 
problems such as Keshan disease, Kashin-Beck disease, carcinogenicity, and 
cardiovascular diseases [31]. In contrast, an estimated safe oral intake of selenium is 5 
µg per day per body weight (kg) for adults, perhaps it differs across regions [31]. 
Although sensitive biochemical indicators of selenium overdose are limited, it has been 
reported that both animals and humans who consume more than a safe level of selenium 
can exhibit hair and nail lesions, peripheral neuropathy and reproductive problems [31, 
33]. Moreover, previous studies have confirmed that selenium also has maternal-fetal 
transfer [36-38]. 
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1.2 Heavy Metals Exposure and Maternal and Newborn’s Health 
Pregnant women and their fetuses are more vulnerable to the adverse effects of 
the exposure to environmental toxic substances [16, 39, 40]. If exposure happens in-
utero, the effect could cause a negative impact in early childhood and later in life; 
through permanent structural and functional changes [41]. Although the placenta may 
act as a selective transporter that prevents the passage of potentially toxic substances to 
the developing fetus, some environmental contaminants can freely or partially cross the 
placental barrier [37]. In particular, arsenic, cadmium and lead are well-known 
environmental heavy metals that could extend the health risk to the fetus even at a low 
concentration through trans-placental circulation [36, 39, 42, 43].  
The toxicologic effects of heavy metals could alter the prenatal stage of human 
development which is a critical period of fetal cell division and differentiation [41]. For 
example, prenatal cadmium exposure could impair steroidogenesis which leads to 
suboptimal fetal growth and development [24]. Lead exposure could interfere with 
calcium deposition into the bone, resulting in decreased fetal bone growth [44]. Arsenic 
exposure during pregnancy may also contribute to placental insufficiencies that could 
lead to intrauterine growth retardation by inducing oxidative stress [45].  
The associations between prenatal exposure to environmental heavy metals and 
adverse birth outcomes have been examined in varying degrees over the last decades. In 
many studies, prenatal arsenic, cadmium and lead exposure were inversely associated 
with the anthropometric measures of newborns such as birth weight, birth length, and 
head circumference [43, 46-50]. Moreover, exposure to these metals also increased the 
risk of preterm delivery [51-53]. Inorganic arsenic exposure during pregnancy was also 
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positively associated with the risks of stillbirth and miscarriage [54]. Although a 
definitive explanation for heavy metals-induced adverse birth outcomes is lacking, these 
metals are known to be involved in oxidative stress induction, hormone interactions and 
direct toxicity which could lead to defective placentation [24, 37, 45]. Since adverse 
birth outcomes could increase the lifelong mortality risk later in life, there has been 
increased awareness with regard to predicting the potential health impact of prenatal 
heavy metals exposure on birth outcomes [55, 56].  
 
1.3 Biological Significance of Telomeres  
1.3.1 Telomere Biology and its Role 
Telomeres are repeated sequences of oligomers (TTAGGG) located at the 
human chromosomal ends. They prevent chromosomal damage by protecting against 
chromosome-chromosome fusions and degradation, thereby maintaining genomic 
integrity [57-59]. Telomere length (TL) is largely maintained by the telomerase RNA 
protein complex and the shelterin proteins whose levels are regulated by human 
telomerase reverse transcriptase (hTERT) and telomerase RNA genes (hTR) [60-64]. 
Telomeric DNA is more sensitive to oxidative stress due to its guanine-rich sequences 
[65, 66]. In addition to direct attack by reactive oxygen species (ROS), the DNA repair 
response is less competent in telomeric DNA than in the majority of other genomic 
DNAs [65]. This is because telomere-related proteins can interfere with the cellular 
responses to breaks on telomeric DNA strands by blocking access to DNA repair 
enzymes [65, 67, 68]. 
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Telomere shortening occurs in normal somatic cells following each cell division 
[62, 64]. Once they reach a certain minimum length, cellular apoptosis occurs because 
of chromosomal end fusion [63, 64]. Based on existing studies, if cellular apoptosis 
does not occur at the critical TL, cells continue to divide due to activation of 
telomerases [57, 60, 62]. Telomerases add the telomere DNA sequences (TTAGGG 
repeats) to prevent chromosomal fusion, resulting in chromosomal instability [62]. 
Dysfunctional telomeres and telomerase activity may, in turn lead to genomic instability 
and malignancy [61, 69, 70]. 
  
1.3.2 Factors Associated with TL and Related Health Risks 
Inter-individual variation in TL can be mostly explained by variation at birth, 
although it also depends on TL attrition rate later in life [66, 71-74]. However, overall 
TL attrition during adulthood is relatively small, meaning that most adults maintain a 
fixed ranking and tracking of TL over their lifetime [71]. In relation to this, a Danish 
twin study estimated that the heritability of TL at baseline was 64% (95% confidence 
interval (CI): 0.39, 0.83) with significant shared environmental effects (estimate = 0.22, 
95% CI: 0.06, 0.49) [74]. The intrauterine environment is potentially plausible for 
newborn TL modification perhaps via fetal programming cascade [75]. Meanwhile, the 
TL attrition rate depends on telomeric DNA susceptibility and responses to the intrinsic 
and/or extrinsic stressors and telomerase enzyme activities [75]. It has been established 
that TL is correlated with aging, exposure to genotoxic agents, oxidative stress and a 
wide range of environmental factors [64, 76-78]. Many factors such as obesity, smoking 
and environmental heavy metals exposure could lead to oxidative stress which in turn 
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accelerates telomere shortening [79-81]. Furthermore, these factors are closely 
associated with inflammatory responses, particularly the production of cytokines that 
could activate telomerase enzymes, resulting in TL shortening [82-85]. However, it is 
difficult to establish the causal relationship between such factors and TL because TL 
alteration could be a direct or indirect systemic effect of a response mechanism. 
Genetic and epigenetic modifications are also associated with telomere 
maintenance. Polymorphisms in telomere-related genes, particularly hTERT genes are 
strongly associated with telomere instability and increased risks of various cancers [86]. 
Moreover, epigenetic regulations, both global DNA methylation and methylation status 
of subtelomeric regions, are involved in telomere dynamics [87, 88]. These epigenetic 
modifications could determine the expression of telomere-related genes which are 
crucial in telomere maintenance.  
An increasing body of evidence has indicated associations between TL and 
pathophysiological outcomes later in life, such as aging, cardiometabolic diseases and 
malignancies [70, 86, 89, 90]. A recent meta-analysis comparing short TL to long TL 
subjects showed that the relative risk of cardiovascular diseases was 1.54 (95% CI: 1.30, 
1.83) [90]. In another study, a shorter TL was found to be significantly associated with 
an increased metabolic risk profile for high-density lipoprotein (β = - 0.016, p = 0.05), 
triglycerides (β = 0.038, p < 0.001), waist circumference (β = 0.647, p = 0.007), and 
fasting blood glucose level (β = 0.011, p < 0.001) [91]. In addition, telomere shortening; 
or lengthening increases the likelihood of malignancies. Therefore, perhaps TL differs 
between the types and stages of cancers. For example, telomere shortening is associated 
with an increased risk of bladder, gastric and oesophageal cancers [92-94], while 
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telomere lengthening increases the risk of melanoma, breast and lung cancers [95-97]. 
Nevertheless, it could be hypothesized that TL alterations could serve as a biomarker of 
a disease or risk; and thus, the assessment of TL could be useful in biomonitoring health 
risks. 
 
1.4 Heavy Metals Exposure and TL 
1.4.1 Arsenic Exposure and TL 
The impact of environmental and occupational arsenic exposure on TL has been 
increasingly concerning. An in vitro study on human cord blood cells stated that the TL 
increased upon exposure to a low concentration of inorganic arsenic (0.001 µM) after 
both 24 hours and 7 days of treatment, while the TL shortened at a high concentration of 
1 µM after 7 days in culture [98]. Another study on human cell lines also supported the 
idea that telomerase activity induced by arsenite concentration at 0.1 - 1 µM resulted in 
telomere elongation, whereas a high concentration (more than 1-40 µM) shortened the 
TL [99]. A prospective cohort study in Bangladesh among 167 participants showed that 
a longer TL was highly prevalent among participants of a high arsenic exposure group 
(urinary arsenic > 339 µg/g) [100]. Another study in India also demonstrated that a 
longer TL was found among an arsenic-exposed population with skin lesions than in the 
control group (odds ratio (OR) 13.75; 95% CI: 5.66, 33.41) [101]. However, a study 
conducted among healthy subjects in Italy revealed an inverse association between 
arsenic exposure and TL (β = - 0.23, p = 0.08) [102]. A cross-sectional study conducted 
in Northern Argentina found no association between urinary arsenic concentration 
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(median value = 230 µg/L) and TL [103]. Based on the existing studies, it is convincible 
that arsenic has a dose-response effect on TL and telomerase activity. 
Without a doubt, arsenic is considered genotoxic since it induces oxidative 
stress; and alters DNA repair and DNA methylation patterns [104-106]. Thus, these 
mechanisms could potentially affect TL maintenance [68]. So far, many studies have 
postulated several possible underlying mechanisms of arsenic-induced TL alterations. 
Arsenic involved in telomere shortening through the mediation of arsenic-induced 
apoptosis, while it is also possible that arsenic-induced oxidative stress directly 
damages the telomeres and telomere-related proteins [79]. Since telomerase activation 
plays a crucial role in telomere maintenance [60, 62], the effect of arsenic on hTERT 
gene expression has also been investigated. A study conducted among the villagers of 
inner Mongolia reported that hTERT expression was highly associated with arsenic 
exposure both in vivo and in vitro [107]. In contrast, a case-control study in India found 
that telomere lengthening was independent on telomerases, and was possibly due to the 
upregulation of shelterin complex proteins such as TRF1 and TRF2, which trigger 
“alternative telomere lengthening” (ATL) [101]. Another study among a Bangladesh 
population also elucidated that arsenic exposure was correlated with the expression of 
other telomere-related genes such as WRC, TERF2, DKC1, TERF2IP, and OBFCI. The 
same study also suggested that alterations in the expression of these genes may cause 
telomere de-protection, contributing to the activation of ATL [100].  
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1.4.2 Cadmium Exposure and TL  
Environmental and occupational exposure to cadmium is associated with TL 
alterations. A handful of recent studies have explored the effect of cadmium on TL. In 
vitro studies of mouse embryonic stem cells showed that telomere shortening was 
triggered by chronic exposure to low-dose cigarette smoke (0.02 mg/mL) or cadmium 
(5-10 µM) [108, 109]. Regarding human studies, a population-based cross-sectional 
study in the U.S. reported that a higher cadmium concentration in both the blood (mean 
blood cadmium = 0.44 µg/dL) and urine (mean urinary cadmium = 0.28 µg/dL) was 
significantly associated with a shorter TL (β = - 5.54; 95% CI: - 0.42, - 0.47 for blood 
and β = - 4.50; 95% CI: - 8.79, - 0.20 for urine) [110]. Similarly, a cross-sectional study 
among Nepalese adolescents also reported that the urinary cadmium concentration 
(geometric mean = 0.19 µg/L) had a significant negative association with salivary TL (β 
= - 0.24; 95% CI - 0.42, - 0.07) [111]. Likewise, a concentration of 0.09 µg/dL 
cadmium initiated the placental telomere shortening (r = - 0.138, p = 0.013) among a 
population in an electronic recycling waste town of China [23].  
 Possible mechanisms of cadmium-induced telomere mutagenicity have been 
proposed in previous studies. Since telomeres are notably sensitive to oxidative stress, 
cadmium could disturb the oxidative stress response by promoting the production of 
ROS [65, 112, 113]. Cadmium may also accelerate telomere shortening by stimulating 
the production of inflammatory chemicals, particularly cytokines [83, 84]. Furthermore, 
cadmium mimics the action of divalent metallic ions such as zinc which could interfere 
with the DNA repair system [114, 115]. Through these processes, cadmium may impact 
TL maintenance. 
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1.4.3 Lead Exposure and TL  
TL could also be modified by environmental lead exposure since inorganic lead 
also exhibits mutagenic, clastogenic and carcinogenic properties [26]. The effects of 
lead exposure on TL have been examined in several studies. A case-control study 
conducted among male lead smelters in Poland reported that telomere shortening was 
associated with a higher blood lead level (mean blood lead level was 33 µg/dL for the 
exposed group and 2.2 µg/dL for the control group) [116]. Another study conducted in 
the southern part of Poland also showed that children had a shorter TL (β = - 0.13; 95% 
CI - 0.23, - 0.02) at the blood lead level of ≥ 3.2 µg/dL [78]. Similarly, a cross-sectional 
study among Chinese battery plant workers reported a strong negative correlation 
between peripheral blood TL and blood lead level (r = - 0.70, p < 0.0001) [117]. 
Conversely, blood lead level was not significantly associated with the relative TL in a 
population-based study using national health and nutrition examination survey data of 
the U.S. from 1999-2002 (mean blood lead level was 1.67 µg/dL) [110]. 
Researchers have speculated about the underlying molecular and biological 
mechanisms of lead-induced genotoxicity. Lead could induce genotoxicity through 
indirect pathways due to oxidative stress or DNA epigenetic modifications [1, 118]. 
Moreover, it may provoke TL alternations by interfering with chromatin organization, 
and causes nuclear membrane impairment, which is crucial for telomere stability [119, 
120]. Lead can also replace calcium, zinc and/or magnesium in enzymes through the 
ionic mechanism of its toxicity, which can ultimately interfere with various biological 
processes including DNA processing and repair [26, 121]. 
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1.4.4 Selenium Exposure and TL 
Selenium is considered an antioxidant and the nutritional level of selenium has 
an anticarcinogenic effect [31, 32]. Despite its antioxidant effect, epidemiological 
studies on the associations between selenium level and TL among human populations 
are limited. An in vitro study on human hepatocyte cell lines demonstrated that the TL 
of hepatocyte L-02 cells was significantly longer at 0.5 and 2.5 µmol/L sodium selenite 
[122]. Another study reported that at doses of 2.5, 5.0 and 10 µmol/kg selenium, the 
telomerase activity of rat hepatocytes increased significantly, supporting the mechanism 
of telomerase-dependent TL elongation [123]. Another study on yeast cells showed that 
selenium-treated cells had a significantly longer TL than control cells (p = 0.031). This 
study also demonstrated that both lead and selenium-treated cells had a longer TL than 
lead alone treated cells, indicating that selenium can repair the damage by the lead to 
some degrees [124]. The antioxidant effect of selenium may involve in protecting or 
repairing of the TL, thereby decelerating telomere aging. It is worth investigating how 
selenium acts and mediates the effects of other metals on TL among human populations. 
  
1.5 TL and Adverse Birth Outcomes 
TL shortening could be associated with the pathophysiology of adverse 
pregnancy outcomes, such as low birth weight and preterm delivery [125-127]. 
Placental cell aging is a physiological adaptive response of rapid cell division during 
pregnancy [125], and TL could be considered as a biomarker of cellular aging [58, 65-
67]. Premature placental aging happens when the intrauterine environment becomes 
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hostile due to intrinsic or extrinsic chemical contaminants, leading to placental 
dysfunction [125]. Placental dysfunction, particularly; decreased placental growth and 
restricted nutriment supply to the developing fetus lead to intrauterine growth restriction 
[125, 127]. In addition, senescent cells may induce the aging process of adjacent cells 
by secreting high levels of inflammatory cytokines, metalloproteinases and epithelial 
growth factors [128]. As a consequence, aging and systemic inflammation may also 
provoke preterm delivery [125]. Hence, cumulative cell damage, shorten TL, may be 
closely associated with low birth weight and preterm birth.  
Previous studies have reported that a shorter TL was associated with preterm, 
preterm premature rupture of membranes (pPROM), stillbirth and fetal growth 
restriction [127, 129-133]. A retrospective study in the Netherlands found that 
individuals born preterm had a significantly shorter TL than individuals born at normal 
term (p = 0.003) [133]. In contrast, in a comparative study of leucocyte TL in three 
groups of pPROM, preterm with intact membranes and normal full-term newborns, the 
TL was not significantly different between pPROM and normal full-term newborns (p = 
0.31); however, preterm newborns had a significantly longer TL than pPROM (p = 
0.05) and normal-term (p < 0.01) newborns [129]. Another study in Italy also reported 
that placental TL shortening was found among the stillbirth group (p < 0.001), 
suggesting that premature aging of the placenta may contribute to the etiology of 
stillbirth [131]. Similarly, the placental TL was significantly shorter among the 
newborns with fetal growth restriction compared to control group in a U.S. study ( p < 
0.001) [127]. 
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Telomerase activity may also play an important role in TL shortening in relation 
to adverse birth outcomes. A previous review reported that complicated pregnancies 
such as preeclampsia and/or fetal growth restriction had decreased or no telomerase 
activity, leading to shortening of the TL [126]. Another study in the U.S also 
demonstrated that higher expression of telomere-induced senescence markers such as 
elongation factor 1 alpha, p 21 and p16 were found among the fetal growth restriction 
group (p < 0.01), indicating that cellular senescence is more frequent among this group 
that may suppress placental telomerase activity [127].  
Heavy metals-induced TL shortening may be an intermediate molecular cause of 
fetal stress and placental apoptosis which leads to adverse birth outcomes. Although a 
definitive explanation for the mechanism of heavy metals-induced adverse birth 
outcomes is not clear, heavy metals are involved in oxidative stress induction, hormone 
interactions and direct toxicity which could lead to defective placentation [16, 24, 40, 
49]. Meanwhile, TL shortening is a biomarker of cumulative oxidative stress [65]. As 
mentioned above, there is an increasing evidence for associations between a shorter TL 
and adverse birth outcomes [127, 129-133]. Taken together, it is possible that TL 
shortening could be a proxy of placental dysfunction which triggers adverse birth 
outcomes.  
  
1.6 Justification  
Heavy metals exposure is likely to modify the TL, which may be associated with 
adverse health risks. However, available information regarding the effect of 
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environmental heavy metals exposure on TL is controversial and limited. Previous 
studies have investigated the effect of heavy metals exposure on TL and telomerase 
gene expression; nevertheless, those studies focused only on adult or adolescent 
populations [100, 101, 103, 110, 111]. In the context of TL, the response to oxidative 
stress is different, even between mother and fetus [129]. Although the trans-placental 
transmission of some heavy metals, such as arsenic, cadmium and lead has been 
investigated [36, 39, 42, 43], so far, only one in vitro study had described the 
associations between prenatal arsenic exposure and newborn TL [98]. Therefore, it is 
important to pay attention to whether in-utero exposure to heavy metals could extend 
the effect to newborn TL. 
Knowledge of newborn TL is relevant because the TL later in life is mainly 
influenced by the TL at birth, meaning that having a short or long TL is greatly defined 
before adulthood [71, 74]. So far, only a handful of studies have identified predictors of 
newborn TL [134-139]. For example, younger paternal age (β = 0.016, 95% CI: 0.004, 
0.028, p = 0.008), higher maternal pre-pregnancy body mass index (β = - 0.52, 95% CI: 
- 0.85, - 0.20, p = 0.002), and lower maternal education (Spearman’s rho = 0.36, p < 
0.01) are independent predictors of a shorter newborn TL [134, 138, 139]. Furthermore, 
maternal pregnancy-related psychological stress was negatively associated with 
newborn TL among a Pennsylvanian population (β = - 0.099, 95% CI: - 0.197, - 0.002, 
p = 0.047) [136]. A recent prospective cohort study in Belgium also determined that 
high prenatal PM2.5 (particulate matter ≤ 2.5 microns in diameter) exposure was 
correlated with a shorter newborn TL (8.8%, 95% CI: - 14.1%, - 3.1%) [135]. Since in 
utero exposure effects are closely correlated with early-life developmental effects and 
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ongoing health risks, partly through epigenetic modifications [140], it is crucial to 
identify the factors that influence TL at birth for preventive measures against human 
disease morbidity and mortality later in life. 
Adverse birth outcomes such as low birth weight and preterm delivery, are 
closely associated with various lifelong mortality and morbidity risks [56, 141]. 
Generally, low birth weight babies are at increased risks of mortality, morbidity and 
disability since it is correlated with poor growth in childhood and an increased 
incidence of many diseases such as hypertension, cardiovascular diseases and type 2 
diabetes mellitus in adulthood [56]. According to the World Health Organization 
(WHO), more than 15% of newborns are born with a birth weight less than 2500 g, with 
the developing countries accounting for more than 95% of them [56]. Preterm delivery 
is another major determinant of neonatal mortality and morbidity [142]. A study of 4 
million early neonatal deaths over 193 countries reported that 28% of neonatal deaths 
were either directly or indirectly due to preterm delivery [143]. A recent systematic 
analysis showed that Southeast Asia accounted for the highest number of preterm birth 
rates in 2010, and estimated that 13.6% were born preterm [141]. Moreover, the 
associations between prenatal heavy metals exposure and adverse birth outcomes have 
been identified in many previous studies [43, 46-50]. Better understanding of the 
etiologic pathway between prenatal heavy metals exposure and adverse outcomes 
among a Myanmar population is relevant for preventive measures. 
Meanwhile, a number of studies have demonstrated that a shorter TL is 
correlated with adverse birth outcomes such as stillbirth, preterm delivery and fetal 
growth restriction [127, 129-133]. Unfavorable conditions in utero can trigger oxidative 
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stress which, in turn causes placental insufficiency, leading to adverse birth outcomes 
[129, 144]. Consequently, adverse birth outcomes could alter TL homeostasis and 
accelerate TL shortening or vice versa [129, 131, 144]. The earlier TL shortening 
happens, the faster the intrinsic organs age, which is closely related to cellular 
dysfunction and disease susceptibility [126]. Therefore, it is important to understand the 
mechanistic pathway between TL homeostasis during fetal development and adverse 
birth outcomes. 
To prevent waterborne infectious diseases, groundwater (from deep well) has 
been substituted as the source of drinking water in Myanmar. However, toxic heavy 
metals contamination in groundwater may increase the risk of many chronic diseases 
[145]. According to the World Bank Policy Report 2005, an estimated 3.4 million 
people were at risk of arsenic contamination mainly through ingestion in Myanmar 
[146]. The southern and central regions of Myanmar are confirmed to be highly 
contaminated with arsenic in the groundwater [145, 147-149]. High arsenic 
concentration in the groundwater has been predicted in the southern part of the country, 
the Ayeyarwady Region, based on the local hydrogeology and climate; reductive 
dissolution of iron oxyhydroxides in groundwater was assumed [147]. According to the 
previous national reports, in the Ayeyarwady Region, of total 123,964 drinking water 
samples; 29.18% are above the WHO standard for an arsenic concentration of 10 μg/L, 
and 8.19% exceed the arsenic concentration of 50 μg/L [148, 149].  
Evidences regarding the other heavy metals contamination is limited in 
Myanmar. As mentioned previously, diet (rice in particular), tobacco smoking, and 
occupational exposure are the major sources of cadmium exposure in general [18]. In 
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Myanmar, only few women smoke, and occupational exposure in possible only in the 
regions where mining is conducted. Diet may be a major source of cadmium exposure 
since Myanmar people usually consume large amount of rice in their daily life. For lead, 
occupational activities such as mining, and battery industries are potential sources of 
exposure. In fact, a previous study conducted in central Myanmar reported that of 18 
water samples, none of them was above the WHO standards of lead concentration (10 
μg/L), and cadmium concentration was below the detection limit of 1 μg/L [145]. Little 
is known about the extent of heavy metals exposure among Myanmar population; 
assessment of exposure using biological samples is necessary. 
Without a doubt, confirmed arsenic contamination is consistently threatening the 
health of Myanmar people. A previous study in central Myanmar reported that increased 
arterial blood pressure and low brachial index were found among those with a nail 
arsenic level higher than 0.09 µg/g [150]. Additionally, among the populations in the 
Ayeyarwady region, a negative association was found between 2-h creatinine clearance 
and a serum arsenic concentration of more than 0.008 µg/L, indicating that chronic 
arsenic exposure may affect renal glomerular function [151]. Despite significant arsenic 
health concerns and potential contamination of other heavy metals in Myanmar [145, 
147], an exposure assessment using biological samples has rarely been conducted 
among a Myanmar population. 
Myanmar is still on the way of progress in reducing neonatal mortality. As 
reported by the Myanmar Demographic and Health Survey 2015-16, the estimated 
infant mortality rate was 40 deaths per 1,000 live births, and more than 60% of deaths 
occurred during the first month [152]. According to the WHO, in Myanmar, the 
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estimated number of low birth weight babies was 179 per 1,000 live births in 2000 and 
the preterm birth rate was 12 per 100 live births in 2010 [56, 141]. In addition to 
investing in maternal and neonatal healthcare services, a wider range of underlying 
etiologic factors should be examined. Although heavy metals contamination has been 
confirmed, no study has determined the extent of prenatal toxicity and the effect of 
those heavy metals exposure on birth outcomes among a Myanmar population. 
 
1.7 Study Objectives 
This study aimed to identify the associations between prenatal heavy metals 
exposure and adverse birth outcomes among pregnant women and newborns in 
Myanmar. This study also aimed to determine the effect of prenatal heavy metals 
exposure on fetal cellular damage by observing newborn leucocyte TL as a biomarker. 
For a better understanding of the etiologic pathway, this study also explored the 
associations between TL and adverse birth outcomes. The study objectives are also 
presented in the following schematic diagram (Figure 1). The findings of this study 
highlight heavy metals-induced newborn leucocyte TL alterations and its relationship 
with adverse birth outcomes which could be beneficial for a better understanding of the 
fetal origin of adulthood diseases. 
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Figure 1: Conceptual Framework  
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Chapter 2: Methods 
2.1 Study Design and Area 
A birth-cohort study was conducted on 493 pregnant women and newborns in 
the Kyaungone and Kyonpyaw Districts of the Ayeyarwady Region, Myanmar 
(Appendix 1). Face-to-face interviews were performed using a questionnaire, and 
maternal spot urine samples were collected during the third trimester. Cord blood 
samples and birth outcomes were evaluated at delivery during the follow-up period of 
one to three months.  
The Ayeyarwady Region is bound on the north by the Bago Region; on the east 
by the Yangon Region and on the south and west by the Bay of Bengal. Geographically, 
the region encloses an area between north latitudes 15° 40' and 18° 30' and between east 
latitudes 94° 15' and 96° 15', covering a total area of 35,140 km2, with a total population 
of 6,184,829. According to Census 2014, the population density in this region was 
180/km². The Ayeyarwady Region has been identified for its high concentration of 
arsenic in the groundwater. According to a national report, of a total tested 123,962 
drinking water samples in 17 townships, approximately 29% contained an arsenic level 
above 10 μg/L, and about 8.2% were higher than 50 μg/L [149]. In terms of water 
sources, shallow or deep tube wells (76.4%) ranked first for highest contamination 
followed by dug wells (21.6%) and surface water (1.9%) [149]. Census 2014 reported 
that approximately 96% of the population relied on tube wells for their primary source 
of drinking water in the Ayeyarwady Region. 
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Three hospitals within approximately two hours of driving participated in this 
study. The included hospitals were township- or station-level public hospitals intended 
to assure accessibility of health services for the general population. All hospitals were 
checked for the availability of basic infrastructure such as electric supply and storage 
areas, during the preliminary situational survey in June, 2016.  
 
2.2 Data Collection Period  
Data collection was conducted from August to December 2016. 
 
2.3 Participants  
Eligible participants were pregnant women aged 18 years and above; residing in 
the study area for more than six months who visited to the health center for antenatal 
care services in the third trimester and with their newborns. Pregnant women who 
suffered from severe medical conditions and those who did not give consent were 
excluded from this study.  
 
2.4 Sample Size 
Data regarding prenatal heavy metals exposure and newborn TL is not yet 
available. In addition, there was no information on the prenatal heavy metals exposure 
among the Myanmar population. Therefore, the sample size was estimated as follows. 
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Sample size = 
𝑧2∗p (1−p)
𝑒2
⁄
1+ 
(𝑧2∗p (1−p))
𝑒2𝑁
 , where z = z-score at 95% CI, p = probability, e = margin 
of error of 5%, and N = population size, assuming that 50% of the population was at 
risk since 58% of the wells in the Ayeyarwady Region had an arsenic concentration of > 
10 µg/L in a previous study [147]. The estimated sample size turned out to be 384. 
Considering the missing value, a total of 493 participants were recruited for this study. 
 
2.5 Terminology and Operational Definitions 
(1) Pregnant women: Women who carry a developing fetus in their uterus, certified 
by medical professionals. 
(2) Newborns: Newborns are just born babies who are only hours old. In this study, 
newborns mean both live births (born alive) regardless of birth outcomes and 
stillbirths (born dead). 
(3) Normal pregnancy outcome: In this study, normal pregnancy outcome was 
defined as term delivery without any complication. 
(4) Adverse birth outcomes: In this study, adverse birth outcomes included low birth 
weight (birth weight < 2500 g at term), preterm delivery (a live birth before 37 
weeks of completed gestation), stillbirth and congenital abnormalities [153]. 
(5) Skilled birth attendants: Skilled birth attendants are skilled health personnel 
(including doctors, nurses and midwives and not including auxiliary midwives 
and traditional birth attendants) who have been educated and trained to be 
proficient in the skills needed to manage normal pregnancies, childbirth, and the 
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immediate postnatal period as well as in the identification, management, and 
referral of complications in women and newborns. 
(6) Telomere length (TL): In this study, relative TL was measured by quantitative 
real-time polymerase chain reaction (PCR). TL was measured as the ratio of 
telomere repeat unit signals to a single copy gene [154]. 
 
2.6 Data Collection  
All of the field work was conducted in collaboration with the local health centers. 
A material transfer agreement was obtained from the Department of Physiology, the 
University of Medicine 1, Yangon and the Department of Medical Research, Ministry 
of Health and Sports, Myanmar to bring back the biological samples to Japan for further 
analysis.  
Before the actual data collection, advocacy and training sessions were conducted 
by the principal researcher at the local health centers. The training session covered the 
objectives of the study, and included an explanation of the questionnaire (Appendix 2) 
and the sampling procedure. Proper instruction (Appendix 3 and 4) was informed to all 
of the local health personnel before biological sample collection. 
Pregnant women who met the eligible criteria were selected from a list of 
antenatal attendance from the district or station health centers. The district or station 
health centers manage all of the maternal and child health programs, including the 
antenatal care services for all sub-divisions of the respective district. Authorized health 
personnel of each sub-division then assisted the research team to trace the eligible 
pregnant women. Those women were approached for in-person interviews and were 
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asked for the drinking water and urine samples. In Myanmar, standardized antenatal 
care is aimed at ensuring that every pregnant woman can have access to at least four 
antenatal visits with quality care by the skilled birth attendants without any financial 
burden [155]. According to the recent Demographic and Health Survey 2015-16, 
approximately 78% of women receive antenatal care from skilled birth attendants in the 
Ayeyarwady Region [152]. 
During the first visit, each participant underwent a pretested face-to-face 
interview for about 30 to 45 minutes by the principal investigator and trained research 
assistants in Myanmar. Questionnaires were initially prepared in English and then 
translated to Myanmar. To enhance the accuracy, it was back-translated into English by 
an independent healthcare staff. A maternal spot urine sample was also collected at the 
first visit. The participants were also asked for a drinking water sample of 20 mL by the 
research team.  
During the follow-up (after 1 to 3 months), the skilled birth attendants collected 
cord blood (3 - 5 mL) at the time of delivery in an ethylene-diamine-tetra-acetic acid 
(EDTA)-coated tube under aseptic conditions. The local skilled birth attendants 
performed the anthropometric measurements and noted the information regarding the 
birth outcomes in the delivery records after birth. It was then extracted for further 
analysis in this study. 
All samples were collected in sterile bottles with respective seals and labels. 
Water samples were properly acidified with nitric acid (grade for analysis of poisonous 
metals, 60%, Wako, Osaka, Japan) at a ratio of 4.5 mL water with 75 μL of 60% nitric 
acid. All samples were firstly stored at - 20 °C at the local health centers. The frozen 
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samples were then transported to the Department of Human Ecology, the University of 
Tokyo, Japan under a cold chain and kept frozen at - 80 °C until experimental analysis.  
 
2.7 Measurements  
2.7.1 Assessment of Heavy Metals Exposure  
Arsenic, cadmium, selenium and lead concentrations in water and maternal urine 
were measured by an assured quality-controlled technique using octapole 
collision/reaction cell inductively coupled plasma mass spectrometry (ICP-MS) 
(Agilent 7500ce ICP-MS, Agilent Technologies, Santa Clara, CA, USA). Original urine 
samples were diluted 20-fold with 1% nitric acid (grade for analysis of poisonous 
metals, 60%, Wako, Osaka, Japan) and 2% 1-butanol (grade for HPLC, 99.5% Nacalai 
Tesque, Kyoto, Japan), and filtered through a 0.45 μm pore membrane (Millipore, 
Billerica, MA, USA) connected to a disposable plastic syringe. ICP multi-elements 
standard solution (XVI CertiPUR, Merck, Darmstadt, Germany) was prepared by the 
gravimetric method to generate a calibration curve. The detection limit (DL) was 
calculated as three times standard deviation (SD) of the procedural blanks. The average 
DL values of arsenic, cadmium, lead and selenium were 0.239, 0.025, 0.843 and 0.362 
μg/L, respectively for urine and 0.015, 0.013, 0.049 and 0.017 μg/L, respectively for 
water. Values under the DL were assumed as a half value of DL. Analytical quality was 
assured by the repeated analysis of the samples against the National Institute of 
Standards and Technology (NIST) Standard Reference Material 1643f Trace Elements 
in Water (NIST, Gaithersburg, MD, USA), National Institute for Environmental Studies 
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(NIES) Certified Reference Material No.18 Human Urine (NIES, Ibaraki, Japan) and 
Seronorm Trace Elements Urine (SERO AS, Billingstad, Norway).  
In this study, maternal urine was used as a biomarker of heavy metals exposure. 
For the studies of a large sample size, less invasive and highly accessible samples are 
relevant as biomarkers [156]. Among this study population, ingestion is a major route of 
exposure, and the amount of exposure may not vary largely day-by-day. Therefore, 
urine samples are expected to reflect the heavy metals exposure among the population 
residing in the study area for considerably long period of time. Urinary arsenic level is 
considered as a robust biomarker of exposure, and is widely used in many 
epidemiological studies since arsenic in the body is mainly excreted in the urine [156]. 
Urinary cadmium level is also an appropriate biomarker because urinary cadmium 
concentration is proportional to the cadmium body burden and accumulation in the 
kidneys [18]. In case of lead, since ingested and inhaled lead is rapidly distributed into 
blood and soft tissues, plasma/blood lead concentration is commonly used as a 
biomarker of exposure; urinary concentration of lead is correlated with plasma/lead 
concentration (r = 0.82, p < 0.01)  [2, 157, 158]. Generally, plasma/blood selenium level 
is considered as a good indicator of selenium status in humans since it reflects the 
nutritional status/intake of selenium more directly [31]. Although urinary selenium level 
is not a robust biomarker, it is also applied in many studies since ingested selenium is 
mainly excreted by urinary route [35, 159], and some studies also reported the 
significant correlations between urinary and plasma (r = 0.52, p < 0.001) selenium 
concentrations [160].   
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All urinary heavy metals concentration measurements were adjusted for 
creatinine. Although 24-hours urine collection is the standard method, creatinine-
adjusted single spot urine had been used to estimate the heavy metals exposure [161-
163]. Considering the complexity and burdens of data collection, spot urine collection 
has frequently used in epidemiological studies that target a large number of subjects 
[163]. The urinary creatinine concentration was measured by the in-vitro colorimetric 
Jaffe method using a commercial kit (LabAssay Creatinine Kit, Wako, Osaka, Japan). A 
linear standard curve was drawn based on five assigned doses of standard solution. 
Absorbance was read at 520 nm on a spectrometer (Molecular Devices SpectraMax, 
Sunnyvale, CA, USA), and the creatinine concentration of each 10-fold diluted urine 
sample was calculated accordingly. 
 
2.7.2 Assessment of Birth Outcomes and Covariates 
The pretested questionnaire covered the variables regarding sociodemographic 
characteristics, drinking water status, anthropological measures, smoking status, 
pregnancy and obstetric history (Appendix 2). Sociodemographic characteristics 
included age, education, occupation, ethnicity and monthly income. Information 
regarding the household drinking water status was also assessed through the 
questionnaire. It included the primary source of drinking water, methods of treatment, 
any information about arsenic testing in the past and reported results. Delivery records 
included information regarding the birth such as birth weight, the baby’s sex, mode of 
delivery, gestational age, and other biological attributes of both mothers and newborns. 
Gestational age at birth was calculated by the date of the last menstrual period as noted 
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in delivery records and the date of childbirth. Low birth weight refers to a birth weight 
of less than 2500 g at term [56] and preterm delivery refers to live delivery before 37 
weeks of completed gestation in accordance with the definition of the International 
Classification of Diseases by the WHO [142]. The birth outcome variables were then 
dichotomized accordingly. 
 
2.7.3 Measurement of Newborn Leucocyte TL 
Genomic DNA was extracted from cord blood into 200 μL of solution using the 
QIAamp DNA Mini and Blood Mini Kit (Qiagen K.K., Tokyo, Japan), according to the 
manufacturer’s instructions. The quality of extracted DNA samples was assured using 
the μDrop plate (Thermo Fisher Scientific, Vantaa, Finland). The ratio of absorbance at 
260 nm to 280 nm was accepted only between 1.7 and 2.2 to maintain the purity of the 
DNA samples. In this study, the relative TL was measured by quantitative real-time 
PCR based on the previously established protocol [111, 154]. PCR was performed on a 
Roche Light Cycler Nano (Roche Diagnostics K.K., Tokyo, Japan). The temperature 
profiles for telomere amplification were set as 40 cycles of denaturation at 95°C for 1s, 
and annealing /extension at 54°C for 60 s; and for 36B4G amplification as 40 cycles at 
95°C for 1s, and annealing/extension at 58°C for 60 s. In addition, melting curve 
analysis was applied to assure the specificity of the products. Two master mixes of PCR 
reagents were prepared, one with telomere primers and the other with 36B4 primers. 
Primers used for telomere PCR are as follows: 
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• tel 1b [5’-CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT-3’] at 
a final concentration of 100 nM 
• tel 2b [5’ -GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT-3’] 
at a final concentration of 900 nM 
Primers used for single-copy gene 36B4 are as follows: 
• 36B4u [5’-CAGCAAGTGGGAAGGTGTAATCC-3’] at a final concentration of 
300 nM 
• 36B4d [5’-CCCATTCTATCATCAACGGGTACAA-3’] at a final concentration 
of 500 nM 
Real-time qualitative PCR determines the fractional cycle number (Ct) at which 
the accumulating fluorescence in the well crosses a set threshold of several standard 
deviations that are higher than the fluorescence. A linear plot of Ct versus the amount of 
targeted DNA input was generated to compare the simple relative quantitation of 
unknowns by the standard curve, which was derived from amplification of the serial 
dilutions of a reference DNA sample in the same plate. The value of crossing point 
deviation of the unknown sample versus the standard was extracted to calculate the TL. 
The relative TL was calculated as the ratio of telomere repeats product to the single- 
copy gene (T/S ratio) for each sample in comparison with reference DNA sample. PCR 
was run for twice for each sample with the respective primers. Samples were made into 
duplicates for each run and accepted only if the SD of the Ct values was less than 1. The 
linearity of the standard curves was satisfactory for both the single-copy gene (mean r2 
= 0.98) and the telomere (mean r2 = 0.94). The inter and intra-experiment coefficients of 
variation (CV) for the single-copy gene were 2.9% and 5.6% respectively, and those for 
the telomere were 8.3% and 8.9%, respectively.  
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2.8 Ethical Considerations 
This study was approved by the Research Ethics Committee of the Graduate 
School of Medicine, the University of Tokyo (No.11186) and the Department of 
Medical Research, Ministry of Health, Myanmar (ERC No.009316). A material transfer 
agreement was obtained through the University of Medicine 1, Yangon, Myanmar. The 
objectives and purposes of the study were explained to all study participants before data 
collection. All the participants were voluntary, and the individuals had given written 
informed consent. 
 
2.9 Data Analysis 
All data were entered and rechecked using Microsoft Excel. Statistical analysis 
was performed using Stata 13 (StataCorp LP, Colledge Station, TX, USA). Urinary 
arsenic, cadmium, selenium and lead concentrations were converted to μg/g creatinine 
after adjusting for creatinine over the entire analysis. Since the urinary heavy metals 
concentration data and relative TL data were non-normally distributed, quartiles 
stratification and natural log-transformation were performed to enhance the normality. 
A descriptive analysis was conducted to present the mean, median, interquartile range 
(IQR), SD and percentage. Correlations between urinary heavy metals concentration 
were first analyzed by Spearman’s correlation. The Wilcoxon rank-sum test was applied 
to compare the exposure levels among different birth outcomes.  
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Multiple logistic regression models were used to identify the associations 
between prenatal heavy metals exposure and adverse birth outcomes. In the models, the 
dependent variable was either low birth weight (0 or 1) or preterm delivery (0 or 1). The 
independent variables included the creatinine adjusted heavy metals concentration of the 
quartile stratifications. Three different models were developed using the quartile 
stratifications of each heavy metal concentration where model 1 was used for bivariate 
analysis, model 2 was used for selenium adjustment and model 3 was used for selenium 
and other confounder adjustments. Associations between prenatal heavy metals 
exposure and TL were also assessed using similar models by bivariate and multivariate 
linear regression. Later, both bivariate and multivariate logistic regression analyses were 
performed to assess whether a shorter TL was associated with the occurrence of adverse 
birth outcomes.  
Potential confounders, such as maternal age, ethnicity, education, gestational age, 
birth weight, parity, the baby’s sex, mode of delivery, and smoking status were included 
in the regression models on the basis of rational associations in previous studies [39, 46, 
52, 129, 164-166]. Regarding the smoking status, the original questionnaire of this 
study included four responses as “smoke before pregnancy”, “smoke during pregnancy”, 
“passive exposure” and “no exposure at all”. However, only 2.1% of the study 
population had a history of smoking (either before or during pregnancy); therefore, this 
section was recategorized into only two sections as “no exposure at all” and “have or 
ever been or passive exposure”. Since gestational age is strongly correlated with both 
low birth weight and preterm delivery, it was excluded in the models of adverse birth 
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outcomes to avoid overestimation. For all analyses, the significance level was set at p-
value of <0.05.  
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Chapter 3: Results 
3.1 Background Characteristics of Participants  
A total of 493 participants were enrolled during their first visit. Of these, only 
419 participants had complete information with regard to delivery and urine samples for 
analysis, and 409 participants provided the cord blood (Figure 2). The background 
characteristics of the participants are presented in Table 1. Of the 419 participants, the 
mean maternal age was 28 years with an SD value of 6.6; 74.2% of participants were 
Bamar ethnic and 46% had completed primary school education. Most participants were 
either housewives (41.9%) or farmers (36.3%). Only 2% had a history of smoking and 
49.2% reported passive exposure.  
 
[Figure 2: Participation Flow Chart of the Study] 
 
[Table 1: Background Characteristics of Participants (n = 419)] 
 
 
3.2 Information Regarding Household Drinking Water 
Table 2 presents information regarding household drinking water among the 
study population. Overall, a bore well or household pumping of groundwater was the 
most common primary source of drinking water in this study area (89.9%). Only 18.5% 
of participants were aware that their water had been previously tested for arsenic. The 
majority of participants (84.0%) practiced some kind of water treatment method before 
drinking. As shown in Figure 2, the most frequent method was traditional cloth filtration 
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(70.2%), followed by boiling (18.9%), settling down (13.0%), using filtering 
equipment/machine (5.7%), chlorination (3.2%) and others (1.0%). 
 
[Table 2: Information Regarding Household Drinking Water (n = 493)] 
 
[Figure 3: Methods of Household Drinking Water Treatment (n = 414)] 
 
 
3.3 Heavy Metals Exposure  
Heavy metals concentration in the household drinking water is presented in 
Table 3. Of the total 248 drinking water samples; arsenic concentration ranged from 
0.02 μg/L to 197.90 μg/L (median = 2.10 μg/L, IQR; 0.48 - 8.79); 22.6% of drinking 
water samples were higher than the WHO standard of 10 μg/L (Appendix 8). 
Table 4 shows the creatinine-adjusted heavy metals concentrations in maternal 
urine. The median values of adjusted maternal urinary concentrations of arsenic, 
cadmium, selenium, and lead were 74.2 μg/g creatinine (IQR, 45.49 - 126.7), 0.9 μg/g 
creatinine (IQR, 0.5 - 1.4), 22.6 μg/g creatinine (IQR, 17.8 - 29.8), and 1.8 μg/g 
creatinine (IQR, 1.0 - 3.4), respectively. The correlation matrix for the concentration of 
heavy metals in maternal urine is presented in Table 5. A strong positive correlation was 
found between the metal pairs, such as arsenic-cadmium (Spearman’s rho = 0.22), 
arsenic-selenium (Spearman’s rho = 0.36) and arsenic-lead (Spearman’s rho = 0.20), 
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regardless of creatinine adjustment. As shown in Table 6, a significant positive 
correlation was also found between the drinking water arsenic concentration and 
maternal urinary arsenic concentration (Spearman’s rho = 0.30, p < 0.001). 
 
[Table 3: Heavy Metals Concentration in Household Drinking Water (n = 248)] 
 
[Table 4: Maternal Urinary Heavy Metals Concentration (n = 419)] 
 
[Table 5: Correlation Matrix of Maternal Urinary Heavy Metals Concentration 
(Spearman’s rho, n = 419)] 
 
[Table 6: Correlations between Heavy Metals Concentration in Drinking Water and 
Maternal Urine (Spearman’s rho, n = 240)] 
 
 
3.4 Maternal Health and Delivery Record Information 
Table 7 presents information regarding the pregnancy and childbirth of the 
participants. The mean gestational age was 38.5 weeks (SD = 1.9). Of the 419 
participants, 67.5% received antenatal care for more than four times, and their first 
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antenatal visit was at the gestational age of 15.6 weeks (SD = 6.1). Among the 
newborns, 56.8% were male and 43.2% were female. The birth weight ranged from 
1510 g to 6300 g, with an average value of 3171.7 g (SD = 493.0). In total, 19% were 
born prematurely and 6% were born as low birth weight babies.  
 
[Table 7: Maternal and Newborn Characteristics (n = 419)] 
 
 
3.5 Prenatal Heavy Metals Exposure and Birth Outcomes 
Tables 8a, 8b and 8c show the associations between maternal urinary heavy 
metals concentration and dichotomous outcomes of low birth weight and preterm 
delivery. Bivariate analysis revealed that an increased risk of low birth weight was not 
significantly associated with a higher maternal urinary cadmium concentration (lowest 
vs highest, odds ratio (OR) = 2.49, 95% CI: 0.90, 6.78, p = 0.078). The association was 
significant (lowest vs highest, adjusted OR (AOR) = 4.79, 95% CI: 1.25, 18.37, p = 
0.022) after adjusting for maternal age, maternal education, the baby’s sex, smoking 
status, primigravida and antenatal visits in the multivariate logistic regression. 
Additional models were also performed including the gestational age and the finding 
was not different. Maternal education (AOR = 0.63, 95% CI: 0.41, 0.98, p = 0.039) and 
primigravida (AOR = 3.73, 95% CI: 1.15, 12.13, p = 0.029) were also found to be 
strong predictors of low birth weight. There was no significant association between 
maternal heavy metals concentration and preterm delivery. 
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[Table 8a: Associations between Prenatal Arsenic Exposure and Adverse Birth 
Outcomes (n = 419)] 
 
[Table 8b: Associations between Prenatal Cadmium Exposure and Adverse Birth 
Outcomes (n = 419)] 
 
[Table 8c: Associations between Prenatal Lead Exposure and Adverse Birth Outcomes 
(n = 419)] 
 
 
3.6 Prenatal Heavy Metals Exposure and Newborn Leucocyte TL 
The median relative TL of the study population was 0.9 (IQR, 0.5 - 1.3). For 
each heavy metal (arsenic, cadmium and lead), three different models were developed to 
examine the associations between heavy metals exposure and TL as presented in Tables 
9a, 9b and 9c. Model 1 was the bivariate analysis of heavy metals concentration and TL. 
The linear regression model 2 was adjusted for selenium concentration to examine the 
mediation effect of selenium. Model 3 was developed by including potential covariates 
such as maternal age, education, ethnicity, smoking status, gestational age, primigravida, 
mode of delivery, the baby’s sex and birth weight in addition to selenium concentration. 
As shown in Table 9a, on bivariate analysis, urinary arsenic concentration was 
significantly associated with a shorter TL (lowest vs highest, coefficient = - 0.17, 95% 
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CI: - 0.26, - 0.08, p < 0.001). The associations remained significant even after adjusting 
for confounders; newborns with higher prenatal arsenic exposure had a shorter TL 
(lowest vs highest, coefficient = - 0.13, 95% CI: - 0.22, - 0.03, p = 0.002) (Table 9a). 
Similarly, cadmium concentration was significantly associated with a shorter TL across 
quartiles (lowest vs highest, coefficient = - 0.19, 95% CI: - 0.28, - 0.08, p < 0.001) 
(Table 9b). As presented in Table 9c, there was also a negative association between lead 
concentration and newborn TL (lowest vs highest, coefficient = - 0.11, 95% CI: - 0.20, - 
0.02, p = 0.020). Selenium concentration did not significantly buffer TL shortening, 
induced by arsenic, cadmium or lead exposure. 
  
[Table 9a: Associations between Prenatal Arsenic Exposure and Newborn Leucocyte 
TL (n = 409)] 
 
[Table 9b: Associations between Prenatal Cadmium Exposure and Newborn Leucocyte 
TL (n = 409)] 
 
[Table 9c: Associations between Prenatal Lead Exposure and Newborn Leucocyte TL 
(n = 409)] 
 
 
3.7 Adverse Birth Outcomes and Newborn Leucocyte TL  
Bivariate analysis followed by multivariate logistic regression was performed to 
identify associations between adverse birth outcomes and newborn leucocyte TL. As 
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shown in Table 10, there was no significant association between newborn TL and any of 
the adverse birth outcomes, specifically, low birth weight (AOR = 0.76, 95% CI: 0.22, 
2.69, p = 0.676) and preterm delivery (AOR = 1.34, 95% CI: 0.60, 3.03, p = 0.476). 
 
[Table 10: Associations between Adverse Birth Outcomes and Newborn Leucocyte TL 
(n = 409)] 
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Chapter 4: Discussion 
4.1 Summary of Findings 
To the best of my knowledge, this is the first study to explore the effect of 
prenatal heavy metals exposure on newborn TL. Moreover, this is the first report on the 
prenatal heavy metals exposure and adverse birth outcomes among a Myanmar 
population. This study revealed that environmental cadmium exposure is comparatively 
high in Myanmar. Prenatal cadmium exposure had a significant association with the 
likelihood of a low birth weight while preterm delivery was not significantly influenced 
by prenatal heavy metals exposure. Prenatal arsenic, cadmium and lead exposure 
significantly shortened the newborn leucocyte TL. The associations were robust even 
after adjusting maternal age, education, ethnicity, smoking status, parity, gestational age, 
mode of delivery, the baby’s sex and baby’s weight. The underlying pathophysiology of 
adverse birth outcomes was not associated with TL shortening in this study. 
     
4.2 Heavy Metals Exposure 
This study firstly examined the extent of heavy metals contamination among the 
Myanmar population. The arsenic concentration of drinking water in this study (22.6%) 
was lower than the previous national report which reported that the arsenic 
concentration in 29.18% of samples was higher than the WHO standards of 10 μg/L 
[149]. This is probably because previous reports directly examined arsenic 
contamination in the source of drinking water while this study assessed the household 
drinking water where treatment and practices before drinking and handling water may 
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have influenced the contamination level. Since there is limited information on the 
concentrations of other heavy metals in Myanmar, the findings of this study support the 
baseline evidence of cadmium, selenium and lead concentrations in the household 
drinking water.  
While assessing heavy metals exposure using biological samples, the urinary 
arsenic concentration among the Myanmar population (74.22 μg/g creatinine) was much 
lower than other exposed populations of Nepal (mean = 196 μg/g creatinine) and India 
(mean = 290 μg/L) [101, 111]. The exposure level of participants examined in this study 
was also lower than the concentration of an unexposed Argentinean population (median 
= 230 μg/L), and Bangladesh population (mean = 154 μg/L) [54, 103]. In the case of 
cadmium, the urinary cadmium concentration in this study (geometric mean (GM) = 
0.86 μg/g creatinine) was comparatively higher than previous findings of non-
industrialized polluted areas of the U.S. (mean = 0.46 μg/g creatinine) and suspected 
contaminated areas of South Africa (GM = 0.27 μg/g creatinine) [167, 168]. The 
exposure level was also higher on comparison with high rice-consuming countries, such 
as Bangladesh (median = 0.63 μg/g creatinine), Nepal (GM = 0.33 μg/g creatinine), and 
China (GM = 0.55 μg/g creatinine) [50, 52, 111]. The median selenium concentration of 
this study was lower than 30 μg/g creatinine which is similar to the concentration of the 
normal reference range [169]. The urinary lead concentration in the present study was 
also found to be in a similar range to those of previous reports from Japan and Korea 
[47, 170]. 
This study also found significant correlations between metals pairs in the 
maternal urine regardless of creatinine adjustment. Even though the possibility of over-
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adjustment by creatinine could not be ruled out, this is in consistence with the previous 
studies which showed the correlations between urinary cadmium-selenium pair (r = 0.16, 
p = 0.02), cadmium-lead pair (r = 0.49, p = 0.00), and arsenic-selenium pair (r = 0.68, p 
< 0.01) [46, 171]. The results are conceivable since accumulation of one metal in body 
could contribute the potential excretion of others. For example, selenium intake can 
influence arsenic methylation, metabolism and urinary excretion [171]. Therefore, the 
correlations are expected because of the coexistence of metals in the body. 
In this study, there was a strong positive correlation between arsenic 
concertation in drinking water and maternal urine (Spearman’s rho = 0.30, p < 0.001). 
The finding of this study suggested that the source of arsenic exposure is probably from 
contaminated drinking water through ingestion. However, regarding cadmium, lead and 
selenium, there was no positive correlation between the drinking water and maternal 
urine, suggesting the importance of tracing the other sources of contamination. Future 
interventions should focus to increase the public awareness on arsenic removal and 
treatment to improve safer water supply.  
This is the first study to detect a comparatively higher concentration of cadmium 
among a Myanmar population. Although smoking being a major source of cadmium 
exposure, there was no significant association between smoking status and urinary 
cadmium concentration in this study. Therefore, these results suggest that the main 
source of cadmium exposure in Myanmar is the diet (either water or food). In a previous 
study comparing the cadmium content in different food items, the GM for cadmium in 
rice (50 ng/g) was significantly higher than that of wheat-derived foods such as bread 
(16 ng/g), flour (19.3 ng/g) and noodles (4 ng/g) [172]. Previous studies also revealed 
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that cadmium from the soil was absorbed and retained in rice to a great extent [173], 
and that cadmium in rice exclusively correlates with the cadmium body burden [174]. In 
Myanmar, rice is the staple food and other rice-derived foods are also major 
components of daily meals. Therefore, it is important to trace the potential sources of 
cadmium contamination while tackling related health concerns in Myanmar. 
 
4.3 Prenatal Heavy Metals Exposure and Birth Outcomes  
This study identified an association between maternal urinary cadmium 
concentration and an increased likelihood of a low birth weight. Low birth weight is 
considered a significant public health concern since it is highly associated with neonatal 
mortality and disease risk in adulthood [175]. Many studies have discussed the effects 
of arsenic, cadmium and lead exposure on several birth outcomes [39, 43, 46-49, 176, 
177]. Among them, cadmium was found to have the most distinct effects on 
anthropometric measures of newborns. For example, a study conducted among the 
Saudi Arabian population reported that the cadmium concentration in umbilical cord 
blood was inversely correlated with crown-heel length, birth weight, Apgar 5-minute 
scores and small for gestational age whereas it was not associated with lead or mercury 
concentration in the same population [43]. This finding is also consistent with previous 
studies where prenatal cadmium exposure led to decreased growth of the fetus in utero, 
leading to decrease in birth weight among the exposed population of similar 
concentrations in Bangladesh (median = 0.63 μg/L), Saudi Arabia (mean = 0.99 μg/L) 
and Japan (GM = 0.77 μg/L) [43, 47, 177]. This effect remained significant at a lower 
concentration (GM = 0.25 μg/L ) among a South Africa coastal population, suggesting 
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that even a lower concentration of cadmium exposure may trigger alterations in fetal 
growth [168].  
The underlying mechanisms of cadmium induced low birth weight have been 
postulated in many previous studies. Cadmium may interfere with zinc transfer to the 
fetus resulting in intrauterine growth retardation [178]. Cadmium may also be involved 
in fetoplacental hormonal alterations such as in the production of placental progesterone, 
thyroid stimulating hormone and placental leptin synthesis which have been linked to 
impaired fetal growth [24, 25, 179]. Moreover, experimental studies have provided 
supportive evidence that cadmium may impair placental circulation, inhibiting the 
transport of nutrients from the mother to the fetus [180, 181]. In contrast with previous 
studies, no association was found between maternal arsenic and lead exposure and low 
birth weight in this study [49, 176, 182]. This could be explained by the comparatively 
low concentrations of urinary arsenic and lead among our study population since 
exposure dose and timing play a critical role in intrauterine fetal growth [183].  
This study also aimed to identify associations between prenatal heavy metals 
exposure and preterm delivery. However, in this study, prenatal heavy metals exposure 
was not significantly associated with preterm delivery. This finding is consistent with a 
previous report in which the arsenic concentration in drinking water was not 
significantly associated with an increased risk of preterm delivery in Taiwan [51]. In the 
case of cadmium, the result is contradictory to previous findings which showed that the 
preterm birth rate was higher with an increased urinary cadmium concentration in China 
and the incidence of preterm delivery among the higher urinary cadmium concentration 
group (≥ 2 nmol/mmol creatinine) was higher than among those with a lower cadmium 
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concentration in Japan [52, 184]. Regarding lead exposure, the result was in line with a 
previous study, conducted among Swedish and Polish women, which revealed that the 
lead concentration in the myometrium and placenta was not significantly elevated in 
preterm delivery compared to term delivery [185] while other studies in China reported 
that a higher maternal blood lead level (≥ 10 μg/dL) doubled the risk of preterm 
delivery [186]. The inconsistencies in results may be explained by differences in 
exposure levels and sensitivity of the population which may vary in response to 
exposure. Moreover, gestational age was typically estimated to determine preterm 
delivery based on the date of last menstrual period and/or ultrasound data [142]. The 
variability in gestational age by regions and assessment protocols may also explain the 
inconsistencies. 
  
4.4 Prenatal Heavy Metals Exposure and Newborn Leucocyte TL 
In the current study, prenatal arsenic exposure was negatively associated with 
newborn TL. A handful of experimental and epidemiological studies have assessed the 
associations between arsenic exposure and TL. However, the findings are limited and 
disputable. For example, there are few contradictory findings that showed a positive 
association between arsenic exposure and TL. Specifically, a study conducted in India 
revealed that arsenic-exposed individuals with skin lesions had a significantly longer TL 
than control subjects [101]. Another study in Bangladesh also reported that a longer TL 
was found among the high exposure group compared to the low exposure group [100]. 
Meanwhile, some studies proposed that arsenic exposure had shortened TL and 
decreased cell survival in animal models and in vitro studies [79, 98]. Consistent with 
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these results, a recent study among Italian young adults also reported a negative 
significant effect of arsenic exposure on leucocyte TL [102]. 
 Contextually, the observation of the current study is plausible when taking into 
consideration the mechanisms of arsenic toxicity, such as the production of ROS, and 
alterations in the DNA repair system which, in turn, could result in telomere shortening 
[65, 79]. Telomeric DNA is more vulnerable to attack by ROS because of its guanine-
rich structures [65]. Telomeric DNA repair function can be affected directly by arsenic-
induced ROS through DNA strands breaking or by activation of genes involved in the 
repair of telomeric DNA [65, 100]. In addition, telomerase activity can be interfered 
with the oxidative DNA damage through subsiding the binding of shelterin complex 
proteins such as TRF1 and TRF2, leading to a deterioration in telomere maintenance 
[187]. The efficacy of arsenic metabolism may also play a role since it can modify the 
effects on telomeres; slower arsenic metabolism could result in a higher risk of arsenic-
induced TL alterations and carcinogenicity [103]. The shortened TL observed in this 
study could be due to the direct and/or indirect damage of TL by arsenic through the 
above-mentioned pathways. In contrast to previous studies among highly-exposed 
populations with clinical manifestations [100, 101, 103], the exposure level in this study 
was comparatively lower. Moreover, this study examined newborns’ TL to diminish the 
combined carcinogenic effects developed by other environmental factors, and the 
duration of exposure was relatively short in our study population. Therefore, the 
inconsistent results are coherent since telomere lengthening could be expected from 
long-term exposure of arsenic and the carcinogenic mode of arsenic may also be 
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involved in telomere lengthening of pre-malignant cells to increase the lifespan [100, 
101].  
Upon quartile stratification of cadmium exposure, this study found a significant 
negative trend across quartiles although the linear association was not significant. Our 
finding is consistent with the previous study among eight years old children in Poland 
which found no linear association between cadmium exposure and TL [78]. Our results 
are also consistent with previous findings, which showed that cadmium exposure 
(highest quartile vs lowest quartile) was inversely associated with TL (β = - 5.54; 95% 
CI: - 0.42, - 0.47 for blood and β = - 4.50; 95% CI: - 8.79, - 0.20 for urine) among the 
U.S adults [110]; and another study among Nepalese adolescents that reported a 
significant linear downward trend between cadmium quintiles and salivary TL (P trend = 
0.01) [111]. However, our results contradict a study in China, which reported that 
placental cadmium concentration was linearly associated with placental telomere 
shortening (r = - 0.138, p = 0.013) [23].  
The effect of cadmium on TL has been biologically postulated in many previous 
studies. Cadmium induces oxidative stress and inflammatory chemicals that can 
potentially accelerate TL shortening [84, 85]. Moreover, cadmium is also an established 
mutagenic metal, involved in the DNA repair system either through ROS induction or 
through enzymatic reaction due to its divalent ion action in replacing zinc ions [114, 
115]. The non-linear association revealed in this study could be explained by the dose of 
cadmium exposure passing the placental barrier during pregnancy and the differing 
study population. Although both inorganic arsenic and arsenic metabolites can freely 
pass through the placental barrier [16], cadmium rather accumulates in the placental 
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tissues; thus, the placental cadmium level was highly correlated with the maternal blood 
cadmium level [38, 42] whereas the maternal blood cadmium level did not correlate 
with cord blood cadmium level [38, 188]. Taken together, it is possible that newborn TL 
was unviolated due to the limited transfer of cadmium from the mother to the fetus 
except at higher concentrations. Therefore, the non-linear association and the negative 
quartile trend between cadmium exposure and newborn TL are conceivable. 
In this study, prenatal lead exposure was also negatively associated with 
newborn TL. In accordance, a study in Poland reported that the blood lead level was 
inversely associated with leucocyte TL among both children (r = - 0.25, p = 0.013) and 
adults (β = - 0.004; p = 0.006) [78, 116]. Another study among Chinese battery workers 
also found an inverse association between the blood lead level and peripheral white 
blood TL (r = - 0.70, p < 0.0001) [117]. In contrast, our finding is contradictory to 
previous results where lead exposure was not associated with placental TL among a 
Chinese population [23] and leucocyte TL among a U.S. population [110].  
Biologically, the effect of lead exposure on TL was recognizable since lead has 
been proven to promote ROS production; by inducing oxidative stress [1, 121]. The 
divalent ionic action of lead could also interfere with the uptake of certain elements 
such as zinc, calcium and magnesium which may ultimately affect DNA repair enzymes 
[26, 121]. Meanwhile, a recent study that examined blood heavy metals concentration 
among pregnant Korean women and their children up to five-years old revealed that 
lead concentration was lowest in the cord blood and highest in 24-36 month-old 
children, suggesting that children are at a higher risk of lead contamination from more 
hand-to-mouth activities at those ages [189]. The effect of lead on TL may be expressed 
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even at a low concentration and cumulative exposure should be considered since it is 
possible that lead exposure may affect TL even after birth in early childhood.  
 This study found no buffering effect of selenium on newborn TL shortening 
induced by arsenic, cadmium or lead. So far, no previous epidemiological study has 
discussed the effect of selenium on TL among a human population. Some experimental 
studies have reported that selenium prevents the shortening of TL on yeast cells due to 
its antioxidant property and it was also shown to exhibit an antimutagenic effect by 
inhibiting telomerase activity in cancer cells [190, 191]. However, the present study 
found no mediation effect of selenium which could probably be explained by the 
interaction between heavy metals that may overcome the effect of selenium on newborn 
TL. 
The findings of the present study underline the importance of heavy metals 
exposure during prenatal life which results in TL shortening. In this study, newborns of 
the highest exposure group had 11% to 19% shorter TL than the lowest exposure group. 
This illustrates that newborns of highly exposed mothers are biologically older than 
newborns of unexposed mothers in terms of TL. This variation at birth may diminish the 
buffering capacity of TL to postnatal influence which may increase the risk of 
adulthood diseases.  
 
4.5 Adverse Birth Outcomes and Newborn Leucocyte TL 
This study found that newborn leucocyte TL was not significantly associated 
with either low birth weight or preterm delivery. Our finding is consistent with a 
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previous report of three cohort studies in Finland, which showed that leucocyte TL did 
not correlate with birth weight, birth height or gestational age at birth in any of the 
cohorts [192]. Our result is also in line with a previous prospective cohort study in the 
U.K., which reported that small for gestational age babies and their mothers had no 
significant shorter TL than term babies [193]. Together with the previous findings, our 
results support the idea that the pathophysiology behind low birth weight and preterm 
delivery was not correlated with newborn telomere homeostasis.  
In contrast, there are also differing results among previous studies. For example, 
a previous study on TL among preterm (< 37 gestational weeks) and full-term (> 37 
gestational weeks) babies found a significant decrease in TL between 27 and 32 weeks 
of gestation while no association was observed between 33 and 42 weeks of gestation 
[194]. These results are in concordance with the explanation that the telomerase activity 
of placental tissues is highest during the first trimester and decreases over time during 
pregnancy [126]. Therefore, the conflicting results are understandable since our study 
recruited pregnant women in their third trimester (mean gestational age = 38.5 weeks) 
to minimize the physiological confounding effect of gestational age on TL. In another 
study, placental TL was significantly lower among intrauterine growth restriction babies 
compared to normal uncomplicated control babies [132]. This inconsistency could be 
explained by the different nature of samples where the present study measured newborn 
leucocyte TL. Placental TL is considered an important factor in the physiology of 
placental development [125, 131, 132]. Across the gestation period, placental cells 
replicate rapidly to fulfil the increasing demands of fetal growth [125]. As an adaptive 
response, placental TL shortening indicates placental aging during pregnancy [131, 132]. 
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Therefore, it is possible that the placental TL may be more responsible for the effects of 
adverse birth outcomes while maintaining fetal homeostasis than fetal TL. 
 
4.6 Strengths and Limitations  
This study drew on many important strengths. The study design was a birth-
cohort prospective design and included a broad information on potential confounders. 
The study was conducted at three public general hospitals to minimize the selection bias. 
Birth outcomes data were extracted from the medical records of township- and district-
level hospitals where well-trained health professionals measured and recorded the birth 
information. In addition, before the actual data collection, advocacy and training 
sessions were given to the local health professionals in advance to make them aware of 
the significance of obtaining accurate information. The concentrations of heavy metals 
were measured using a sensitive, robust and well-validated method (ICP-MS), and was 
assured with certified reference materials. Multiple important heavy metals were 
examined rather than focusing on only one heavy metal. TL was measured from a 
highly accessible source of DNA, blood leucocytes since leucocyte TL is largely 
heritable and the attrition may be influenced by environmental factors [195, 196]. 
Moreover, this is the first study to determine whether prenatal heavy metals exposure 
affects newborns TL. This is also the first report on the extent of prenatal heavy metals 
exposure and its associations with adverse birth outcomes among a Myanmar 
population. 
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Some limitations should also be addressed in this study. The present study failed 
to control the genetic factors and prenatal exposure to other toxic chemicals which 
could collectively affect the outcomes. Nutritional intake was not fully considered in 
this study, although it is an important predictor of low birth weight [197]. Although the 
antenatal attendance is more than 78% in this study area [152], there is the possibility of 
missing eligible participants. Information on birth outcomes was extracted from the 
hospitals’ medical records, which may differ according to measurement protocols. 
Regarding TL, this study raised some issues to be focused on in future research. 
Maternal TL should be measured to investigate the mode of inheritance from mothers to 
newborns. It would also be worthwhile to perform a longer prospective study with 
repeated measurements of TL and the assessment of health outcomes later in life.  
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Chapter 5: Conclusions and Perspectives 
The present study provides baseline information concerning environmental 
heavy metals exposure among a Myanmar population. This study revealed that 
Myanmar mothers are comparatively highly exposed to cadmium which should be 
considered a public health threat. Prenatal exposure to cadmium was positively 
associated with low birth weight in Myanmar. Furthermore, this is the first study to 
reveal the impact of prenatal heavy metals exposure on newborn TL. This study 
identified that a strong and independent inverse association between prenatal arsenic, 
cadmium and lead exposure and newborn TL. However, the risk of adverse birth 
outcomes was not associated with newborn leucocytes TL in this study.  
Based on existing research, the TL at birth predicts the TL later in life, and the 
findings of this study revealed that in utero heavy metals exposure could predict TL at 
birth. Therefore, future public health measures should integrate interventions to reduce 
heavy metals contamination with special emphasis on pregnant women. Meanwhile, 
compelling prospective studies are warranted to predict the early life developmental 
effects and ongoing health risks among individuals with a shorter TL. Considering TL 
as a biomarker, future insights should incorporate the dose-response effect of 
environmental heavy metals exposure risks to foresee preceding and/or present diseases 
which could provide further important insights into the mechanisms of disease 
processes. 
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Table 1: Background Characteristics of Participants (n = 419) 
Characteristics n  % Mean  SD 
Age (years) 419  27.9 6.6 
Religion     
 Buddhist  376 89.7   
 Christian 41 9.8   
 Others  2 0.5   
Ethnicity     
 Bamar  311 74.2   
 National races†  106 25.3   
 Others 2 0.5   
Education     
 Illiterate  7 1.7   
 Read and write  66 15.8   
 Primary school completed 193 46.1   
 Middle school completed  81 19.3   
 High school completed  44 10.5   
 Graduate and above  28 6.9   
Occupation      
 Unemployed or housewives  176 41.9   
 Farmers 152 36.3   
 Private sectors 8 1.9   
 Government officers 14 3.3   
 Own business 32 7.6   
 Others  37 8.8   
Monthly household income # (USD) 296  124.2 55.7 
Hospitals     
 Kyaungone 153 36.5   
 Kyonpyaw 139 33.2   
 Ahtaung 127 30.3   
Smoking status     
 Not at all 210 50.1   
 Have or ever been or passively exposed  209 49.9   
†National races include Kachin, Kayar, Kayin, Chin, Mon, Yakhine and Shan. 
# 1 USD = 1224 MMK as of Sep, 2016. 
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Table 2: Information Regarding Household Drinking Water (n= 493) 
Characteristics Number Percentage 
Primary source of drinking water   
 Bore well/Hand pump/ Motor pump 419 89.9 
 Community well 14 2.8 
 River/ Lake water/Rain water  6 1.2 
 Household water supply (Municipal piped) 10 2.0 
 Others 44 8.5 
Duration of primary water source   
 Less than 2 years 125 25.3 
 2 – 20 years 253 51.3 
 More than 20 years 85 17.2 
 Don’t know 30 6.1 
Any treatment before drinking    
 No  79 16.0 
 Yes 414 84.0 
If yes, how often   
 Always  390 94.2 
 Usually 14 3.4 
 Sometimes  10 2.4 
 Few 0 0 
Water testing   
 Within 1 month 20 4.1 
 Within 1 – 3 months  45 9.9 
 Within 3 – 6 months  73 14.8 
 More than 6 months  144 29.2 
 Never 199 40.4 
 Missing  8 1.6 
Ever been tested for arsenic   
 No  245 49.7 
 Yes  91 18.5 
 Don’t know 157 31.8 
If yes, results   
 Above standard (>= 50 μg/L) 12 13.2 
 Below standard (< 50 μg/L) 59 64.8 
 Don’t know 20 22 
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Table 3: Heavy Metals Concentration in Household Drinking Water (n = 248) 
Concentration (μg/L) Median IQR Detection Limit 
Arsenic  2.10 (0.48 – 8.79) 0.015 
Cadmium  0.01 (0.01 – 0.01) 0.013 
Selenium  0.01 (0.01 – 0.02) 0.017 
Lead 0.02 (0.02 – 0.02) 0.049 
 
 
80 
 
Table 4: Maternal Urinary Heavy Metals Concentration (n = 419) 
Concentration Median IQR Detection Limit 
Unadjusted for Creatinine (μg/L)    
Arsenic  55.18 (30.54 – 94.56) 0.239 
Cadmium  0.62 (0.31 – 1.08) 0.002 
Selenium  16.40 (10.19 – 25.6) 0.361 
Lead 1.33 (0.42 – 2.89) 0.843 
Adjusted for Creatinine  
(μg/g creatinine) 
   
Arsenic  74.22 (45.48 – 126.67)  
Cadmium  0.86 (0.50 – 1.40)  
Selenium  22.57 (17.79 – 29.78)  
Lead 1.80 (1.04 – 3.43)  
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Table 5: Correlation Matrix of Maternal Urinary Heavy Metals Concentration 
(Spearman’s rho, n=419) 
 Arsenic  Cadmium  Selenium  Lead 
Unadjusted for Creatinine  
Arsenic  1.00    
Cadmium  0.41* 1.00   
Selenium  0.60* 0.64* 1.00  
Lead  0.44* 0.51* 0.62* 1.00 
Adjusted for Creatinine 
Arsenic  1.00    
Cadmium  0.22* 1.00   
Selenium  0.36* 0.41* 1.00  
Lead  0.20* 0.27* 0.26* 1.00 
* p < 0.001 
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Table 6: Correlations between Heavy Metals Concentration in Drinking Water 
and Maternal Urine (Spearman’s rho, n = 240) 
Variable Spearman’s rho p - value 
Water arsenic – urine arsenic 0.30 < 0.001 
Water cadmium – urine cadmium - 0.14 0.03 
Water lead – urine lead - 0.02 0.08 
Water selenium – urine selenium - 0.09 0.69 
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Table 7: Maternal and Newborn Characteristics (n = 419)  
Characteristics n  % Mean  SD 
Gestational age (weeks) 419  38.5 1.9 
Primigravida      
 No  181 43.2   
 Yes 238 56.8   
Antenatal visits      
 Less than four times  136 32.5   
 four or more than four times  283 67.5   
Gestational week of first antenatal visit  419  15.6 6.1 
Mode of delivery     
 Normal spontaneous delivery  188 44.9   
 Assisted delivery ᵞ  7 1.7   
 Cesarean delivery   224 53.5   
Baby’s sex     
 Male  238 56.8   
 Female  181 43.2   
Birth weight (g) 419  3171.7 493.0 
Birth outcomes     
 Normal alive 329 78.5   
 Stillbirth 2 0.5   
 Preterm ᶿ 80 19.1   
 Congenital abnormality 2 0.5   
 Low birth weight † 26 6.2   
Relative leucocyte TL (T/S ratio) 409  0.9 ª (0.5 – 1.3) ᵇ 
ᵞ Assisted delivery includes vacuum or forceps deliveries. 
ᶿ Any delivery before 37 weeks of gestation regardless of birth weight. 
† Birth weight < 2500 g regardless of gestational age at birth. 
TL: Telomere length. ª Median. ᵇ IQR.
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Table 8a: Associations between Prenatal Arsenic Exposure and Adverse Birth Outcomes (n= 419) 
 
Characteristics 
Low Birth Weight † Preterm ᵞ 
Model 1  ͣ  Model 2 ᵇ Model 3 c Model 1  ͣ  Model 2 ᵇ Model 3 c 
OR (95% CI) AOR (95% CI) AOR (95% CI) OR (95% CI) AOR (95% CI) AOR (95% CI) 
Arsenic concentration ᶿ        
  Quartile 1 (< 45.5) ref ref ref ref ref ref 
  Quartile 2 (45.5 – 74.2) 1.53 (0.47, 4.98) 1.55 (0.47, 5.13) 1.23 (0.36, 4.25) 0.80 (0.40, 1.59) 0.79 (0.39, 1.59) 0.80 (0.38, 1.66) 
  Quartile 3 (74.2 – 126.7) 1.71 (0.54, 5.41) 1.78 (0.54, 5.83) 1.75 (0.51, 6.04) 0.77 (0.39, 1.53) 0.79 (0.39, 1.59) 0.89 (0.43, 1.87) 
  Quartile 4 (> 126.7) 1.40 (0.48, 4.73) 1.41 (0.39, 5.08) 1.13 (0.29, 4.35) 1.06 (0.54, 2.06) 1.15 (0.57, 2.32) 1.28 (0.61, 2.70) 
Selenium concentration ᶿ        
  Quartile 1 (< 17.8)  ref ref  ref ref 
  Quartile 2 (17.8 – 22.6)  0.71 (0.23, 2.14) 0.65 (0.20, 2.03)  1.84 (0.91, 3.71) 1.55 (0.76, 3.20) 
  Quartile 3 (22.6 – 29.8)  0.44 (0.13, 1.55) 0.43 (0.11, 1.60)  1.65 (0.81, 3.36) 1.39 (0.66, 3.20) 
  Quartile 4 (> 29.8)  0.91 (0.31, 2.66) 0.92 (0.30, 2.91)  0.94 (0.42, 2.09) 0.76 (0.33, 1.74) 
Maternal age (years)   1.05 (0.98, 1.13)   1.03 (0.98, 1.07) 
Maternal education   0.63 (0.40, 0.97) *   0.87 (0.69, 1.11) 
Primigravida  
(ref: non primigravida) 
  4.29 (1.36, 13.55) *   1.75 (0.90, 3.41) 
Antenatal visits ≥ 4 times  
(ref: < 4 times) 
  0.59 (0.25, 1.39)   1.33 (0.75, 2.08) 
Mode of delivery 
(ref: normal vaginal delivery) 
  0.63 (0.27, 1.48)   0.42 (0.25, 0.70) ** 
Baby’s sex (ref: male)   1.61 (0.70, 3.68)   1.25 (0.75, 2.08) 
Smoking Status (ref: no exposure)   0.97 (0.42, 2.22)   1.55 (0.92, 2.61) 
*p < 0.05. ** p < 0.01.  
ᶿ Adjusted for creatinine (μg/g creatinine); † Birth weight < 2500 g regardless of gestational age at birth; ᵞ Any delivery before 37 weeks 
of gestation regardless of birth weight. 
a Bivariate logistic regression; b Multivariate logistic regression adjusted for selenium concentration; c Multivariate logistic regression 
adjusted for maternal age, maternal education, parity, baby’s sex, mode of delivery, smoking status and selenium concentration.
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Table 8b: Associations between Prenatal Cadmium Exposure and Adverse Birth Outcomes (n= 419) 
 
Characteristics 
Low Birth Weight † Preterm ᵞ 
Model 1  ͣ  Model 2 ᵇ Model 3 c Model 1  ͣ  Model 2 ᵇ Model 3 c 
OR (95% CI) AOR (95% CI) AOR (95% CI) OR (95% CI) AOR (95% CI) AOR (95% CI) 
Cadmium concentration ᶿ        
  Quartile 1 (< 0.5) ref Ref ref ref ref ref 
  Quartile 2 (0.5 – 0.9) 0.34 (0.07, 1.71) 0.34 (0.07, 1.73) 0.36 (0.07, 1.91) 1.42 (0.72, 2.78) 1.49 (0.75, 2.94) 1.41 (0.69, 2.87) 
  Quartile 3 (0.9 – 1.4) 0.91 (0.27, 3.09) 1.12 (0.32, 3.91) 1.16 (0.31, 4.40) 1.20 (0.60, 2.40) 1.16 (0.60, 2.37) 1.09 (0.51, 2.32) 
  Quartile 4 (> 1.4) 2.47 (0.90, 6.78) 3.38 (1.10, 10.43) * 4.79 (1.25, 18.37) * 0.93 (0.46, 1.92) 0.98 (0.57, 2.11) 0.86 (0.36, 2.05) 
Selenium concentration ᶿ        
  Quartile 1 (< 17.8)  Ref ref  ref ref 
  Quartile 2 (17.8 – 22.6)  0.65 (0.21, 2.01) 0.53 (0.16, 1.72)  1.80 (0.89, 3.63) 1.53 (0.74, 3.16) 
  Quartile 3 (22.6 – 29.8)  0.29 (0.08, 1.06) 0.26 (0.64, 1.02)  1.75 (0.85, 3.61) 1.53 (0.72, 3.25) 
  Quartile 4 (> 29.8)  0.52 (0.16, 1.66) 0.43 (0.12, 1.49)  1.01 (0.45, 2.25) 0.88 (0.38, 2.03) 
Maternal age (years)   0.99 (0.92, 1.08)   1.03 (0.98, 1.08) 
Maternal education   0.63 (0.41, 0.98) *   0.88 (0.69, 1.12) 
Primigravida  
(ref: non primigravida) 
  3.73 (1.15, 12.13) *   1.79 (0.92, 3.46) 
Antenatal visits ≥ 4 times  
(ref: < 4 times) 
  0.54 (0.23, 1.28)   1.29 (0.73, 2.28) 
Mode of delivery 
(ref: normal vaginal delivery) 
  0.58 (0.24, 1.39)   0.42 (0.25, 0.70) ** 
Baby’s sex (ref: male)   1.52 (0.64, 3.58)   1.26 (0.75, 2.11) 
Smoking status (ref: no exposure)   0.87 (0.37, 2.01)   1.53 (0.91, 2.56) 
*p < 0.05, ** p < 0.01, ***p < 0.001.  
ᶿ Adjusted for creatinine (μg/g creatinine); † Birth weight < 2500 g regardless of gestational age at birth; ᵞ Any delivery before 37 weeks 
of gestation regardless of birth weight. 
a Bivariate logistic regression; b Multivariate logistic regression adjusted for selenium concentration; c Multivariate logistic regression 
adjusted for maternal age, maternal education, parity, baby’s sex, mode of delivery, smoking status and selenium concentration.
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Table 8c: Associations between Prenatal Lead Exposure and Adverse Birth Outcomes (n= 419) 
 
Characteristics 
Low Birth Weight † Preterm ᵞ 
Model 1  ͣ  Model 2 ᵇ Model 3 c Model 1  ͣ  Model 2 ᵇ Model 3 c 
OR (95% CI) AOR (95% CI) AOR (95% CI) OR (95% CI) AOR (95% CI) AOR (95% CI) 
Lead concentration ᶿ        
  Quartile 1 (< 1.0) ref ref ref Ref ref ref 
  Quartile 2 (1.0 – 1.8) 0.86 (0.32, 2.33) 0.82 (0.30, 2.24) 1.00 (0.34, 2.90) 1.04 (0.52, 2.05) 1.10 (0.55, 2.18) 1.22 (0.60, 2.49) 
  Quartile 3 (1.8 – 3.4) 0.57 (0.18, 1.75) 0.57 (0.18, 1.78) 0.56 (0.18, 1.87) 0.94 (0.47, 1.91) 0.94 (0.46, 1.91) 0.98 (0.47, 2.05) 
  Quartile 4 (> 3.4) 0.44 (0.13, 1.49) 0.43 (0.12, 1.51) 0.43 (0.12, 1.58) 1.13 (0.70, 2.23) 1.19 (0.58, 2.41) 1.22 (0.58, 2.54) 
Selenium concentration ᶿ        
  Quartile 1 (< 17.8)  ref ref Ref ref ref 
  Quartile 2 (17.8 – 22.6)  0.76 (0.25, 2.29) 0.71 (0.22, 2.23)  1.80 (0.89, 3.61) 1.52 (0.74, 3.12) 
  Quartile 3 (22.6 – 29.8)  0.56 (0.16, 1.94) 0.57 (0.15, 2.16)  1.61 (0.79, 3.29) 1.40 (0.66, 2.96) 
  Quartile 4 (> 29.8)  1.21 (0.43, 3.44) 1.19 (0.39, 3.64)  0.93 (0.43, 2.02) 0.78 (0.35, 1.73) 
Maternal age (years)   1.04 (0.97, 1.12)   1.02 (0.98, 1.07) 
Maternal education   0.63 (0.41, 0.98) *   0.86 (0.68, 1.10) 
Primigravida  
(ref: non primigravida) 
  4.06 (1.31, 12.52) *   1.71 (0.89, 3.29) 
Antenatal visits ≥ 4 times  
(ref: < 4 times) 
  0.53 (0.22, 1.26)   1.30 (0.73, 2.29) 
Mode of delivery  
(ref: normal vaginal delivery) 
  0.60 (0.25, 1.42)   0.41 (0.25, 0.70) ** 
Baby’s sex (ref: male)   1.61 (0.70, 3.69)   1.25 (0.75, 2.08) 
Smoking status (ref: no exposure)   0.90 (0.39, 2.06)   1.53 (0.91, 2.56) 
*p < 0.05. ** p < 0.01.  
ᶿ Adjusted for creatinine (μg/g creatinine); † Birth weight < 2500 g regardless of gestational age at birth; ᵞ Any delivery before 37 weeks of gestation 
regardless of birth weight. 
a Bivariate logistic regression; b Multivariate logistic regression adjusted for selenium concentration; c Multivariate logistic regression adjusted for 
maternal age, maternal education, parity, baby’s sex, mode of delivery, smoking status and selenium concentration.  
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Table 9a: Associations between Prenatal Arsenic Exposure and Newborn Leucocyte Telomere Length (n = 409) 
 
Characteristics  
Model 1  ͣ  Model 2 ᵇ Model 3 c 
Coefficient (95% CI) Coefficient (95% CI) Coefficient (95% CI) 
Arsenic concentration ᶿ     
  Quartile 1 (< 45.5) Ref ref ref 
  Quartile 2 (45.5 – 74.2) - 0.07 (- 0.15, 0.19) - 0.06 (- 0.15, 0.26) - 0.06 (- 0.15, 0.03) 
  Quartile 3 (74.2 – 126.7) - 0.14 (- 0.22, - 0.05) ** - 0.12 (- 0.21, - 0.03) ** - 0.11 (- 0.20, - 0.02) ** 
  Quartile 4 (> 126.7) - 0.17 (- 0.26, - 0.08) *** - 0.15 (- 0.24, - 0.05) ** - 0.13 (- 0.22, - 0.03) ** 
Selenium concentration ᶿ     
  Quartile 1 (< 17.8)  ref ref 
  Quartile 2 (17.8 – 22.6)  0.03 (- 0.06, 0.12) 0.03 (- 0.06, 0.12) 
  Quartile 3 (22.6 – 29.8)  - 0.03 (- 0.12, 0.06)  - 0.03 (- 0.12, 0.06)  
  Quartile 4 (> 29.8)   - 0.06 (- 0.15, 0.04)  - 0.05 (- 0.15, 0.04) 
Maternal age (years)   - 0.004 (- 0.01, 0.002) 
Maternal education   0.005 (- 0.02, 0.03) 
Gestational age (weeks)   - 0.003 (- 0.02, 0.01) 
Birth weight (g)   0.00 (- 0.00, 0.00) 
Primigravida (ref: non primigravida)   - 0.03 (- 0.11, 0.05) 
Ethnicity (ref: Bamar)   0.01 (- 0.07, 0.05) 
Mode of delivery  
(ref: normal vaginal delivery) 
  - 0.03 (- 0.10, 0.04) 
Baby’s sex (ref: male)   - 0.03 (- 0.09, 0.03) 
Smoking status (ref: no exposure)   - 0.01 (- 0.07, 0.05) 
** p < 0.01. ***p < 0.001  
ᶿ Adjusted for creatinine (μg/g creatinine) 
a Bivariate linear regression; b Multivariate linear regression adjusted for selenium concentration; c Multivariate linear regression adjusted 
for maternal age, maternal education, gestational age, birth weight, parity, ethnicity, baby’s sex, mode of delivery, smoking status, 
cadmium, lead and selenium concentration.
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Table 9b: Associations between Prenatal Cadmium Exposure and Newborn Leucocyte Telomere Length (n = 409) 
 
Characteristics  
Model 1  ͣ  Model 2 ᵇ Model 3 c 
Coefficient (95% CI) Coefficient (95% CI) Coefficient (95% CI) 
Cadmium concentration ᶿ    
  Quartile 1 (< 0.5) ref ref ref 
  Quartile 2 (0.5 – 0.9) - 0.05 (- 0.13, 0.04) - 0.04 (- 0.13, 0.05) - 0.05 (- 0.14, 0.04) 
  Quartile 3 (0.9 – 1.4) - 0.13 (- 0.22, - 0.04) ** - 0.12 (- 0.21, - 0.03) ** - 0.14 (- 0.23, - 0.04) ** 
  Quartile 4 (> 1.4) - 0.19 (- 0.28, - 0.10) *** - 0.17 (- 0.26, - 0.08) *** - 0.19 (- 0.30, - 0.08) *** 
Selenium concentration ᶿ    
  Quartile 1 (< 17.8)  ref ref 
  Quartile 2 (17.8 – 22.6)  0.03 (- 0.05, 0.12) 0.03 (- 0.06, 0.12) 
  Quartile 3 (22.6 – 29.8)  - 0.01 (- 0.10, 0.08)  - 0.02 (- 0.11, 0.07) 
  Quartile 4 (> 29.8)  - 0.04 (- 0.13, 0.06) - 0.03 (- 0.13, 0.06) 
Maternal age (years)   0.002 (- 0.004, 0.01) 
Maternal education   0.00 (- 0.03, 0.03) 
Gestational age (weeks)   - 0.00 (- 0.02, 0.02) 
Birth weight (g)   - 0.00 (- 0.00, 0.00) 
Primigravida (ref: non primigravida)   - 0.02 (- 0.10, 0.06) 
Ethnicity (ref: Bamar)   0.02 (- 0.05, 0.08) 
Mode of delivery (ref: normal vaginal delivery)   - 0.02 (- 0.09, 0.04) 
Baby’s sex (ref: male)   - 0.01 (- 0.08, 0.05) 
Smoking status (ref: no exposure)   - 0.01 (- 0.05, 0.08) 
** p < 0.01. ***p < 0.001  
ᶿ Adjusted for creatinine (μg/g creatinine) 
a Bivariate linear regression; b Multivariate linear regression adjusted for selenium concentration; c Multivariate linear regression adjusted 
for maternal age, maternal education, gestational age, birth weight, parity, ethnicity, baby’s sex, mode of delivery, smoking status and 
selenium concentration. 
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Table 9c: Associations between Prenatal Lead Exposure and Newborn Leucocyte TL (n = 409) 
 
Characteristics  
Model 1  ͣ  Model 2 ᵇ Model 3 c 
Coefficient (95% CI) Coefficient (95% CI) Coefficient (95% CI) 
Lead concentration ᶿ    
  Quartile 1 (< 1.0) ref ref ref 
  Quartile 2 (1.0 – 1.8) - 0.10 (- 0.19, - 0.01) * - 0.09 (- 0.18, - 0.00) * - 0.09 (- 0.18, - 0.00) * 
  Quartile 3 (1.8 – 3.4) - 0.04 (- 0.13, 0.04) - 0.04 (- 0.13, 0.05) - 0.04 (- 0.13, 0.05) 
  Quartile 4 (> 3.4) - 0.14 (- 0.23, - 0.05) ** - 0.11 (- 0.20, - 0.02) * - 0.11 (- 0.20, - 0.02) * 
Selenium concentration ᶿ    
  Quartile 1 (< 17.8)  ref ref 
  Quartile 2 (17.8 – 22.6)  0.02 (- 0.07, 0.11) 0.01 (- 0.08, 0.10) 
  Quartile 3 (22.6 – 29.8)  - 0.04 (- 0.13, 0.05)  - 0.05 (- 0.14, 0.05)  
  Quartile 4 (> 29.8)   - 0.08 (- 0.17, 0.01) - 0.08 (- 0.17, 0.01) 
Maternal age (years)    - 0.002 (- 0.01, 0.004) 
Maternal education   0.01 (- 0.02, 0.04) 
Gestational age (weeks)   - 0.001 (- 0.02, 0.02) 
Birth weight (g)   0.00 (- 0.00, 0.00) 
Primigravida (ref: non primigravida)   - 0.02 (- 0.10, 0.06) 
Ethnicity (ref: Bamar)   0.02 (- 0.05, 0.09) 
Mode of delivery (ref: normal vaginal delivery)   - 0.03 (- 0.10, 0.03) 
Baby’s sex (ref: male)   - 0.03 (- 0.09, 0.04) 
Smoking status (ref: no exposure)   - 0.00 (- 0.07, 0.06) 
*p < 0.05. ** p < 0.01.  
ᶿ Adjusted for creatinine (μg/g creatinine) 
a Bivariate linear regression; b Multivariate linear regression adjusted for selenium concentration; c Multivariate linear regression adjusted for 
maternal age, maternal education, gestational age, birth weight, parity, ethnicity, baby’s sex, mode of delivery, smoking status and selenium 
concentration. 
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Table 10: Associations between Adverse Birth Outcomes and Newborn Leucocyte Telomere Length (n = 409) 
 
 
Characteristics 
Low Birth Weight † Preterm ᵞ 
OR 
(95% CI) 
AOR 
(95% CI) 
OR 
(95% CI) 
AOR 
(95% CI) 
Relative TLᶿ (T/S ratio) 0.73 (0.21, 2.48) 0.76 (0.22, 2.69) 1.40 (0.65, 2.99) 1.34 (0.60, 3.03) 
Maternal age (years)  1.05 (0.97, 1.13)  1.03 (0.99, 1.08) 
Maternal education   0.69 (0.44, 1.03)  0.89 (0.70, 1.14) 
Primigravida (ref: non primigravida)  4.07 (1.31, 12.66) *  1.76 (0.91, 3.38) 
Antenatal visits ≥ 4 times (ref: < 4 times)  0.62 (0.26, 1.45)  1.45 (0.82, 2.56) 
Mode of delivery (ref: normal vaginal delivery)  0.61 (0.26, 1.41)  0.37 (0.22, 0.63) *** 
Baby’s sex (ref: male)  1.43 (0.62, 3.28)  1.18 (0.71, 1.96) 
Smoking status (ref: no exposure)  0.85 (0.37, 1.96)  0.85 (0.37, 1.96) 
*p < 0.05. ***p < 0.001.  
ᶿ Log-transformed value. 
† Birth weight < 2500 g regardless of gestational age at birth. 
ᵞ Any delivery before 37 weeks of gestation regardless of birth weight.  
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Figure 2: Participation Flow Chart of the Study  
 
Completed Urine Sampling 
n = 466 
First Visit  
Completed Interview 
n = 493 
Failed to come to deliver at the health centers (n = 37) 
or did not have identification number of urine samples 
(n = 10) or cord blood (n = 10) 
 
 
Failed to give urine samples after the interview 
(n = 27) 
 
Analytical Sample 
n = 419 (Complete questionnaires + urine samples + 
birth outcomes data) 
n = 409 (Complete questionnaires + urine samples + 
birth outcomes data+ cord blood samples) 
Follow-up  
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ᶿ Multiple responses were allowed. 
 
Figure 3: Methods of Household Drinking Water Treatment ᶿ (n = 414)  
  
13.0%
18.9%
3.2%
70.2%
5.7%
Cloth Filter
Chlorination
Boiling 
Settle Down 
Filter Equipment/ 
Machine 
Others  1.0%
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Appendix 1: Map of Study Area 
 
Source: UNICEF and MOH, 2013  
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Appendix 2: Questionnaire (English Version) 
SURVEY QUESTIONNAIRE (English version) 
Identification: 
Township:  
 
Ward name: 
Interviewer 
Name: 
 
Date of interview:            /           / 
                                      
Field Editor Data Entry 
Name: 
Date:             /             / 
Name: 
Date:            /             / 
       
Introduction 
Mingalarbar! 
My name is                  . We are interviewing pregnant women in their third trimesters about 
the drinking water status and pregnancy and child birth. The information you give to me is 
confidential. The result of this survey will be used to help improve health programs for 
women. 
Eligibility 
Pregnant women (aged 18 years or above) in their third trimesters, residing in the study 
area for more than six months. 
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Instruction: Circle the answers, which are responded by the participants or fill in the 
blank areas. Thank you for your participation. 
Part (A) 
1. Socio-demographic characteristics 
No Questions Answers Codes Note 
1. In what month and year were 
you born? 
………. Month 
………. Year 
Don’t know  
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2. How old are you? (Completed 
year) 
   
3. What is your religion? Buddhist  1  
Christian  2 
Muslim  3 
Hindu  4 
Others 5 
4. What is your ethnicity? Bamar 1  
National races 2 
Others 3 
5. What is the highest education 
or year of school you 
completed? 
Illiterate  1  
Read and write 2 
Primary school completed 3 
Middle school completed 4 
High school completed 5 
Graduate and above  6 
6. What is your main 
occupation? 
Unemployed  1  
House-wife 2 
Farmers  3 
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Private sectors  4 
Government servants 5 
Own business 6 
Others 7 
7. Do you or have you worked 
for any of the following? 
Armed force  1 Multiple 
responses are 
possible  
Glass industry 2 
Coal mine/Refinery  3 
Saw mill 4 
Cotton field/Orchid 5 
Mining/Smelting 6 
Electronic plants  7 
None of these  8 
8. If yes, how long do you or 
have you worked? 
For …………. 
At …………… 
  
9. How much is monthly 
household income? 
In local currency (kyats) 
…………… 
Skip if the 
respondent is 
unemployed  
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2. Assessment of Quality of Drinking Water 
No Questions Answers Codes Note 
1. Which of the following 
sources of drinking water are 
available in your 
neighborhood? 
Bore well/Hand pump/ 
Motor pump  
1 Multiple 
responses 
are possible Community well 2 
River/Lake water 3 
Household water supply 
(Municipal piped) 
4 
Rain water  5 
Others (Specify) 6 
2. What is your primary source of 
drinking water? 
Bore well/Hand pump/ 
Motor pump 
1 Single 
response 
Community well 2 
River/Lake water 3 
Household water supply 
(piped) 
4 
Rain water  5 
Others (Specify) 6 
3. How long it had been as the 
primary drinking water 
source? 
 
……………………… 
 If the 
dwelling 
spot is 
changed, 
please count 
the duration 
from the new 
dwell. 
4. If the primary source of 
drinking water is shallow or 
 
…………………….. 
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deep well, please mention how 
deep is it? 
Don’t know 99 
5. Do you treat your water in any 
way to make it safer to drink? 
No 0 If No, skip to 
question no 
6. 
Yes 1 
6. If yes, how often do you treat? Always  1  
Usually  2 
Sometimes 3 
Few  4 
7. If yes, what do you usually do 
your water to make it safer to 
drink? 
Boil 1 Multiple 
responses 
are possible 
Add bleach/Chlorine  2 
Strain it through a cloth 3 
Use a water filter 
(ceramics, sand, 
composite, etc.) 
4 
Solar disinfection  5 
Let it stand and settle  6 
Others (Specify) 7 
8.. When was the last time the 
water was tested? 
< 1month  If Never skip 
to question 
no 9.  
Within 1- 3 months  
Within 3 - 6 months  
More than 6 months   
Never   
9.. What was it tested for? Bacteria 1  
Chemicals   2 
Others  3 
10. Who (Which organization) did 
the testing? 
Government 
Organizations  
1  
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NGOs/NPOs 2 
Other 3 
11. Has it ever been tested for 
arsenic? 
No  0  
Yes  1 
12.. If yes, what were the results? Above standard  
(> 10 µg/L) 
1  
Below standard  
(<= 10 µg/L) 
2 
Don’t know  3 
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3. Food Consumption 
No. Questions Answers Codes Note 
How often, in the past 3 months, did you eat the following? 
1. Seafood Never  1  
< 1 time per week 2 
1 - 6 times per week 3 
1 - 3 times per day 4 
≥ 4 times per day  5 
2. Rice or other cooked grains 
including brown rice, 
cracked wheat and millet  
(per 3 meals in a day) 
Almost never or never 1  
About ⅓ of the time  2 
About ⅔ of the time  3 
Almost always or always 4 
3.  Ways of rice cooking  Traditional boiling method  1  
Absorption method (by rice 
cooker)  
2 
Others  3 
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4. Maternal Health during Pregnancy  
No. Questions Answers Codes Note 
1. How many months 
pregnant are you? 
………….. months    
2. Is this your first 
pregnancy? 
No 0  
Yes 1 
3. If no, how many of 
pregnancies resulted in a 
baby that was born alive 
or born dead? 
Baby born alive …. 
Baby born dead …. 
Abortion……... 
  
4. Did your most recent 
birth result in a baby that 
was born alive or dead? 
Live birth 1  
Stillbirth 2  
5. If live birth, in which 
month and year did your 
most recent birth occur? 
   
6. How many times in total 
have you received 
antenatal care during 
your current pregnancy? 
 
………..  
  
7. How many months 
pregnant were you when 
you first received 
antenatal care for this 
pregnancy? 
 
………..  
  
8. Whom did you first see 
for checkup on your 
current pregnancy? 
Doctor  1  
 
 
 
 
 
Nurse/Midwife 2 
TBA/Traditional healer   3 
Community health worker 4 
Relative/Friend  5 
Others  6 
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9. Which arrangement 
have your or your family 
made for the birth of this 
child. 
 
N
o
  
Y
es
 
 
Transport 0 1 
Save money  0 1 
A blood donor 0 1 
A skilled provider 0 1 
A safe delivery place 0 1 
Others (Specify) 0 1 
10. During the antenatal 
period, did you 
experience any serious 
health problems? 
No 0  
Yes 1 
11. If yes, what problems 
did you experience? 
Severe vaginal bleeding  1  
Severe vaginal discharge   2 
Convulsion  3 
High fever 4 
Loss of consciousness 5 
Swollen hands/face  6 
Severe headache  7 
Severe abdominal pain  8 
Water breaks without labor 9 
Accelerated/reduced fetal 
movement  
10 
Others(Specify) 99 
12. Are you suffering any 
underlying medical 
disease?  
No 0 If yes, 
state. 
……… 
Yes 1 
13. Are you currently taking 
any medication? 
No  0 If yes, 
state. 
……… 
Yes  1 
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14. How is your smoking 
status? 
 
N
o
 
Y
es
  
Smoke before pregnancy 0 1 
Smoke during pregnancy 0 1 
Second hand exposure to 
smoking 
0 1 
Never smoke or being exposed 0 1 
15. How is your alcohol 
drinking status? 
 
N
o
 
Y
es
  
Drink before pregnancy  0 1 
Drink during pregnancy 0 1 
Never drink 0 1 
Clinical and Laboratory Information from Antenatal Record 
16. Body Weight     
17. Height     
18. Temperature     
19. Edema    
20. Pulse     
21. Blood Pressure     
22. Hemoglobin     
23. Urine test (AI/sugar)    
24. Malaria     
25. Prophylactic Treatment   
N
o
 
Y
es
  
Tetanus toxoid 0 1 
Iron  0 1 
Folic acid 0 1 
Vitamin B1 (B complex) 0 1 
26. Any diagnosed 
pregnancy related 
complication 
 
……………………… 
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Part (B) 
Identification: 
Township: Ward name: 
Interviewer 
Name: 
 
Date of interview:            /           / 
                                      
Field Editor Data Entry 
Name: 
Date:             /             / 
Name: 
Date:            /             / 
 
5. Delivery Record of Mothers and Newborns  
No. Questions Answers Codes Note 
Maternal Information  
1. Admission Date    
2. Contraction Started  Date  
Time 
  
3. Maternal weight …………. (kg)   
4. Maternal height ………….. (m²)   
5. Obstetric complications 
during pregnancy  
Antenatal hemorrhage 1  
Postpartum hemorrhage 2 
Postpartum sepsis 3 
Severe pre-
eclampsia/Eclampsia 
4 
Ruptured uterus 5 
Labor lasting >12 hours  6 
Placenta not delivered 30 
minutes after baby  
7 
Others (Specify) 99 
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Nil 98 
6. Any referral history No  0  
Yes 1 
7. Reason of referral  ……………………….   
Newborns Information  
6. Date of Birth     
7. Sex    
8. Birth weight     
9. Height     
10. Head Circumference     
11. APGAR score     
12. Type of Delivery  Normal spontaneous vaginal 
delivery 
1  
Assistant delivery (vacuum 
extraction or forceps) 
2  
Cesarean section  3  
13. Presentation  ……………………….   
14. Delivery Outcomes  Live birth  1  
Stillbirth  2 
IUFD 3 
Premature 4 
Twins  5 
Congenital abnormalities 6 
Others  7 
15. Baby to Breast/ Suck  Within 1 hour 1  
> 1 hour  2 
None 3 
 
Thank you so much for your cooperation.
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Appendix 3: Instruction for Urine Sampling  
 
Maternal spot urine is collected at the time of antenatal visit at third trimesters 
by the research team. 
 
1) Collect spot urine of about 5 – 20 mL from the pregnant women. 
2) Fasting or special diet is not necessarily to be requested. 
3) Urine samples are initially collected in storage 60 mL plastic cabinet and then 
transfer to 5 mL polyethylene tubes with airtight lids. 
4) Avoid contact with the inside or refrain from leaving the tubes open to air longer 
than necessary to minimize the external contamination. 
5) Label identification number and keep frozen immediately. 
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Appendix 4: Instructions for Cord Blood Sampling 
The fetal cord blood is to be collected shortly after the delivery under aseptic 
conditions. Procedures are almost the same for non-cesarean section and cesarean 
section. 
1) A segment of cord must be separated between two sets of clamps 
immediately after delivery as normal procedure permits. 
2) Ensure that the cord segment is full of blood. If needed, perform milking of 
the cord before clamping. 
3) Recommended for a segment of cord (about 8 inches) be separated from the 
rest of the cord and placenta to allow the third stage to continue without 
further interruption. 
4) Choose a site 4 - 6 inches from the cut end of umbilical cord for the cord 
blood sampling. 
5) Clean the chosen site using septic swabs, wiping the entire width of cord 
about 4 inches nearby the in-situ site.  
6) Using the sterile syringe, insert the needle into the chosen (cleaned) site of 
umbilical vein of cord and draw about 5 mL of cord blood. 
7) Transfer the collected blood into the provided vacuum tubes containing 
anticoagulant. 
8) Proper labeling of respective identification numbers and keep frozen within 
1 hour. 
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Appendix 5: Ethical Approval Letter (the University of Tokyo) 
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Appendix 6: Ethical Approval Letter (Department of Medical Research, 
Myanmar) 
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Appendix 7: Material Transfer Agreement 
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Appendix 8: Arsenic Concentration in Drinking Water, Stratified by the WHO 
Guidelines (n = 248) 
Arsenic Concentration  Number  Percentage 
< 10 μg/L 192 77.4 
≥ 10 μg/L 56 22.6 
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Appendix 10: Newborn Leucocyte Telomere Length Across the Quartiles of (A) 
Arsenic and (B) Cadmium (n = 409) † 
 
 
(A) 
 
(B) 
† Quartile exposure levels (μg/g creatinine) for arsenic are 1st < 45.5, 2nd 45.5 – 74.2, 3rd 
74.2 – 126.7 and 4th > 126.7, and for cadmium are 1st < 0.5, 2nd 0.5 – 0.9, 3rd 0.9 – 1.4 
and 4th > 1.4. 
